<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Genetics</journal-id>
<journal-id journal-id-type="iso-abbrev">Genetics</journal-id>
<journal-id journal-id-type="hwp">genetics</journal-id>
<journal-id journal-id-type="pmc">genetics</journal-id>
<journal-id journal-id-type="publisher-id">genetics</journal-id>
<journal-title-group>
<journal-title>Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0016-6731</issn>
<issn pub-type="epub">1943-2631</issn>
<publisher>
<publisher-name>Genetics Society of America</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28874452</article-id>
<article-id pub-id-type="pmc">5586389</article-id>
<article-id pub-id-type="publisher-id">203067</article-id>
<article-id pub-id-type="doi">10.1534/genetics.117.203067</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Model Organisms Facilitate Rare Disease Diagnosis and Therapeutic Research</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wangler</surname>
<given-names>Michael F.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5245-5910</contrib-id>
<xref ref-type="aff" rid="aff1">*</xref>
<xref ref-type="aff" rid="aff2">
<sup>†</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>‡</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>§</sup>
</xref>
<xref ref-type="author-notes" rid="afn1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yamamoto</surname>
<given-names>Shinya</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2172-8036</contrib-id>
<xref ref-type="aff" rid="aff1">*</xref>
<xref ref-type="aff" rid="aff3">
<sup>‡</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>§</sup>
</xref>
<xref ref-type="aff" rid="aff5">**</xref>
<xref ref-type="author-notes" rid="afn1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chao</surname>
<given-names>Hsiao-Tuan</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>†</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>‡</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>††</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Posey</surname>
<given-names>Jennifer E.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4814-6765</contrib-id>
<xref ref-type="aff" rid="aff1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Westerfield</surname>
<given-names>Monte</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>‡‡</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Postlethwait</surname>
<given-names>John</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5476-2137</contrib-id>
<xref ref-type="aff" rid="aff7">
<sup>‡‡</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<collab>Members of the Undiagnosed Diseases Network (UDN)</collab>
<xref ref-type="fn" rid="fn2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hieter</surname>
<given-names>Philip</given-names>
</name>
<xref ref-type="aff" rid="aff8">
<sup>§§</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boycott</surname>
<given-names>Kym M.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4186-8052</contrib-id>
<xref ref-type="aff" rid="aff9">***</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Campeau</surname>
<given-names>Philippe M.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9713-7107</contrib-id>
<xref ref-type="aff" rid="aff10">
<sup>†††</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bellen</surname>
<given-names>Hugo J.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5992-5989</contrib-id>
<xref ref-type="aff" rid="aff1">*</xref>
<xref ref-type="aff" rid="aff3">
<sup>‡</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>§</sup>
</xref>
<xref ref-type="aff" rid="aff5">**</xref>
<xref ref-type="aff" rid="aff11">
<sup>‡‡‡</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>3</sup>
</xref>
</contrib>
<aff id="aff1"><label>*</label>Department of Molecular and Human Genetics, Baylor College of Medicine (BCM), Houston, Texas 77030</aff>
<aff id="aff2"><label>†</label>Department of Pediatrics, Baylor College of Medicine (BCM), Houston, Texas 77030</aff>
<aff id="aff3"><label>‡</label>Jan and Dan Duncan Neurological Research Institute, Texas Children’s Hospital, Houston, Texas 77030</aff>
<aff id="aff4"><label>§</label>Program in Developmental Biology, Baylor College of Medicine (BCM), Houston, Texas 77030</aff>
<aff id="aff5"><label>**</label>Department of Neuroscience, Baylor College of Medicine (BCM), Houston, Texas 77030</aff>
<aff id="aff6"><label>††</label>Department of Pediatrics, Section of Child Neurology, Baylor College of Medicine (BCM), Houston, Texas 77030</aff>
<aff id="aff7"><label>‡‡</label>Institute of Neuroscience, University of Oregon, Eugene, Oregon 97403</aff>
<aff id="aff8"><label>§§</label>Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia V6T 1Z4C, Canada</aff>
<aff id="aff9"><label>***</label>Children’s Hospital of Eastern Ontario Research Institute, University of Ottawa, Ontario K1H 8L1, Canada</aff>
<aff id="aff10"><label>†††</label>Department of Pediatrics, University of Montreal, Quebec H3T 1C5, Canada</aff>
<aff id="aff11"><label>‡‡‡</label>Howard Hughes Medical Institute, Baylor College of Medicine (BCM), Houston, Texas 77030</aff>
</contrib-group>
<author-notes>
<fn fn-type="equal" id="afn1">
<label>1</label>
<p>These authors contributed equally to this work.</p>
</fn>
<corresp id="cor1"><label>3</label>Corresponding author: Baylor College of Medicine, 1250 Moursund St., Suite 1125, Houston, TX 77030. E-mail: <email>hbellen@bcm.edu</email></corresp>
</author-notes>
<!--Fake ppub date generated by PMC from publisher
					pub-date/@pub-type='epub-ppub' -->
<pub-date pub-type="ppub">
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>31</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>31</day>
<month>8</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>207</volume>
<issue>1</issue>
<fpage>9</fpage>
<lpage>27</lpage>
<history>
<date date-type="received">
<day>14</day>
<month>4</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>7</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2017 by the Genetics Society of America</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="open-access">
<license-p>Available freely online through the author-supported open access option.</license-p>
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri xlink:href="9.pdf" xlink:title="pdf" xlink:type="simple"></self-uri>
<abstract>
<p>Efforts to identify the genetic underpinnings of rare undiagnosed diseases increasingly involve the use of next-generation sequencing and comparative genomic hybridization methods. These efforts are limited by a lack of knowledge regarding gene function, and an inability to predict the impact of genetic variation on the encoded protein function. Diagnostic challenges posed by undiagnosed diseases have solutions in model organism research, which provides a wealth of detailed biological information. Model organism geneticists are by necessity experts in particular genes, gene families, specific organs, and biological functions. Here, we review the current state of research into undiagnosed diseases, highlighting large efforts in North America and internationally, including the Undiagnosed Diseases Network (UDN) (Supplemental Material, <ext-link ext-link-type="uri" xlink:href="http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.117.203067/-/DC1/FileS1.docx">File S1</ext-link>) and UDN International (UDNI), the Centers for Mendelian Genomics (CMG), and the Canadian Rare Diseases Models and Mechanisms Network (RDMM). We discuss how merging human genetics with model organism research guides experimental studies to solve these medical mysteries, gain new insights into disease pathogenesis, and uncover new therapeutic strategies.</p>
</abstract>
<kwd-group>
<kwd>functional genomics</kwd>
<kwd>
<italic>Drosophila</italic>
</kwd>
<kwd>zebrafish</kwd>
<kwd>human</kwd>
<kwd>genetic diseases</kwd>
<kwd>whole-exome sequencing</kwd>
<kwd>diagnostics</kwd>
</kwd-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="3"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="155"></ref-count>
<page-count count="19"></page-count>
</counts>
</article-meta>
</front>
<body>
<p>DISEASE diagnosis, one of the primary goals of medicine, is a process to discover the origin or nature of disease in a particular patient. Without an accurate diagnosis, we can neither identify the cause nor design an effective treatment strategy to suppress or ameliorate the condition. Many patients with rare conditions undergo a “diagnostic odyssey,” a long and frustrating journey to obtain an accurate diagnosis. Several organizations have estimated that ∼80% of these undiagnosed diseases have a genetic origin (<xref ref-type="bibr" rid="bib69">IOM 2010</xref>).</p>
<p>Advanced technology is increasingly important for diagnosis and has been transformative for rare Mendelian disorders (<xref ref-type="bibr" rid="bib55">Gonzaga-Jauregui <italic>et al.</italic> 2012</xref>). Whole-exome sequencing (WES) has emerged as an effective diagnostic tool for patients who have undergone comparative genomic hybridization methods to rule out chromosomal abnormalities (<xref ref-type="bibr" rid="bib101">Need <italic>et al.</italic> 2012</xref>; <xref ref-type="bibr" rid="bib151">Yang <italic>et al.</italic> 2013</xref>, <xref ref-type="bibr" rid="bib152">2014</xref>; <xref ref-type="bibr" rid="bib80">Lee <italic>et al.</italic> 2014</xref>; <xref ref-type="bibr" rid="bib114">Retterer <italic>et al.</italic> 2016</xref>). However, sequencing also uncovers many rare variants for which the functional impact is not known (<xref ref-type="bibr" rid="bib33">Coventry <italic>et al.</italic> 2010</xref>; <xref ref-type="bibr" rid="bib89">Lupski <italic>et al.</italic> 2011</xref>), and interpretation can be difficult as healthy individuals often carry alleles that would be deleterious or lethal when homozygous (<xref ref-type="bibr" rid="bib50">Gao <italic>et al.</italic> 2015</xref>). Model organism studies can be a pivotal resource for understanding these variants (<xref ref-type="bibr" rid="bib150">Yamamoto <italic>et al.</italic> 2014</xref>). In many cases, studying genes simultaneously in humans and model organisms provides additional insight into the cause of a particular disease, thereby contributing to an understanding of the pathogenic processes.</p>
<p>Studying human genomic variants in model organisms is facilitated by collaboration between clinicians and model organism researchers (<xref ref-type="bibr" rid="bib65">Hieter and Boycott 2014</xref>; <xref ref-type="bibr" rid="bib96">McGurk <italic>et al.</italic> 2015</xref>; <xref ref-type="bibr" rid="bib20">Bonini and Berger 2017</xref>; <xref ref-type="bibr" rid="bib26">Chao <italic>et al.</italic> 2017b</xref>; <xref ref-type="bibr" rid="bib91">Manolio <italic>et al.</italic> 2017</xref>). We highlighted the importance of model organisms, particularly the fruit fly <italic>Drosophila melanogaster</italic>, in the context of human biology (<xref ref-type="bibr" rid="bib142">Wangler <italic>et al.</italic> 2015</xref>), and described how model organism researchers are becoming integral to disease research. The questions we raised about the future of model organism research, and subsequent discussion at <ext-link ext-link-type="uri" xlink:href="https://www.youtube.com/watch?v=f9FXNU1YWQo">The Allied Genetics Conference in 2016, which included the Director of the National Institutes of Health (NIH)</ext-link>, made clear the priority <ext-link ext-link-type="uri" xlink:href="https://nexus.od.nih.gov/all/2016/07/14/a-look-at-trends-in-nihs-model-organism-research-support/">that model organism research should have in biomedical research</ext-link>.</p>
<p>In this article, we show how model organism research can be integral to unraveling the molecular mechanisms of disease. We begin this discussion with illustrative examples that document the value model organisms have brought to human disease research, including Mendelian diseases and cancer. We highlight three approaches for engaging model organism laboratories with the expanding list of human genes and variants requiring functional annotation. We primarily focus on two model organisms—<italic>Drosophila</italic> and zebrafish (<xref ref-type="fig" rid="fig1">Figure 1</xref>)—and highlight large-scale efforts in the United States (US) and Canada that integrate model organisms into human disease diagnosis and therapy development. Projects such as the <ext-link ext-link-type="uri" xlink:href="https://undiagnosed.hms.harvard.edu/">Undiagnosed Diseases Network (UDN)</ext-link> with its centralized Model Organisms Screening Center (MOSC) (<xref ref-type="bibr" rid="bib48">Gahl <italic>et al.</italic> 2016</xref>), <ext-link ext-link-type="uri" xlink:href="https://undiagnosed.hms.harvard.edu/research/model-organisms/">the Centers for Mendelian Genomics (CMG)</ext-link> (<xref ref-type="bibr" rid="bib28">Chong <italic>et al.</italic> 2015</xref>) and the <ext-link ext-link-type="uri" xlink:href="http://www.rare-diseases-catalyst-network.ca/">Canadian Rare Diseases Models and Mechanisms Network (RDMM)</ext-link> provide exciting opportunities for model organism researchers, human geneticists, and clinicians to collaborate to determine the potential pathogenicity of disease-linked rare variants, gain deeper pathophysiological understanding of diseases, and discover potential treatments and therapies for patients and families. Lessons learned from these complementary projects will likely lead to the establishment of an efficient framework for facilitating the diagnosis and study of rare diseases.</p>
<fig fig-type="figure" id="fig1" position="float">
<label>Figure 1</label>
<caption>
<p>Collaborations among clinicians, human geneticists and model organism researchers facilitate diagnosis and studies of undiagnosed conditions. Candidate causative genes and variants identified from a patient with an undiagnosed disease can be explored in a number of genetic model organisms. Using state-of-the-art genome engineering technologies in these model systems, one can assess whether the variants of interest lead to functional consequences <italic>in vivo</italic>, and obtain phenotypic information that may directly or indirectly relate to the patient’s condition. Integration of biological information from multiple species can be complementary or/and confirmatory.</p>
</caption>
<graphic xlink:href="9fig1"></graphic>
</fig>
<sec id="s1">
<title>Evolutionary Conservation of Genes and Pathways: Orthologs and Phenologs</title>
<p>Biologists often focus on differences among organisms. Indeed, the diversity of life is staggering. Our first impulse is to assume that this diversity arises from different developmental mechanisms, and that these processes must rely on different genes, signaling pathways, and molecular events. For example, it is difficult to comprehend that a fruit fly or a fish could share many genes and signaling pathways with humans. They differ in so many morphological features, and their physiology seems so different, that we tend to imagine there are no or very few commonalities. It was therefore surprising when it became apparent in the 1980s and 1990s that numerous genes are conserved across species and are used repeatedly in many different contexts.</p>
<p>In the past 25 years it became apparent that many biological processes are evolutionarily conserved, and that discoveries in yeast, worms, and flies have a direct relevance to vertebrate and human biology. The 2016 Nobel Prize in Physiology or Medicine was awarded to Yoshinori Ohsumi for his pioneering genetic studies in yeast that led to the discovery and mechanistic understanding of autophagy, a fundamental process involved in cancer, neurological disorders, and other diseases (<xref ref-type="bibr" rid="bib131">Takeshige <italic>et al.</italic> 1992</xref>; <xref ref-type="bibr" rid="bib136">Tsukada and Ohsumi 1993</xref>; <xref ref-type="bibr" rid="bib98">Mizushima <italic>et al.</italic> 1998</xref>). Similar major discoveries with yeast include the identification of core mediators of the cell cycle (<xref ref-type="bibr" rid="bib63">Hartwell <italic>et al.</italic> 1970</xref>, <xref ref-type="bibr" rid="bib64">1974</xref>; <xref ref-type="bibr" rid="bib105">Nurse and Bissett 1981</xref>; <xref ref-type="bibr" rid="bib9">Balter and Vogel 2001</xref>) and mechanistic understanding of vesicle trafficking (<xref ref-type="bibr" rid="bib104">Novick <italic>et al.</italic> 1980</xref>) (2001 and 2013 Nobel Prizes, respectively). Other insights arose from the study of invertebrate animals, including the discovery of molecular mechanisms of learning and memory in the sea slug <italic>Aplysia</italic> (<xref ref-type="bibr" rid="bib73">Kandel 2001</xref>) (2000 Nobel Prize), RNA interference (<xref ref-type="bibr" rid="bib45">Fire <italic>et al.</italic> 1998</xref>) and apoptotic pathways (<xref ref-type="bibr" rid="bib43">Ellis and Horvitz 1986</xref>) in the nematode worm <italic>Caenorhabditis elegans</italic> (2006 and 2002 Nobel Prizes, respectively), and identification of conserved developmental genes and pathways (<xref ref-type="bibr" rid="bib85">Lewis 1978</xref>; <xref ref-type="bibr" rid="bib106">Nusslein-Volhard and Wieschaus 1980</xref>) and innate immunity mechanisms (<xref ref-type="bibr" rid="bib83">Lemaitre <italic>et al.</italic> 1996</xref>) in <italic>Drosophila</italic> (1995 and 2011 Nobel Prizes, respectively) had major impacts on biomedical research. Basic knowledge obtained from model organism research is now being translated to mammalian contexts with remarkable speed. For example, control of organ growth and size was shown to be regulated by genes of the Hippo signaling pathway in flies in 2003 (<xref ref-type="bibr" rid="bib57">Halder and Johnson 2011</xref>). It took only a few years to show that this pathway is conserved in humans and that it plays a critical role in organ growth, cancer, and regeneration (<xref ref-type="bibr" rid="bib117">Saucedo and Edgar 2007</xref>).</p>
<p>Conservation of genes and processes extends to numerous physiological pathways. For example, genes encoding proteins that play important roles in synaptic transmission, action potential propagation, and many other forms of neuronal communication or muscle function are highly conserved and play similar roles in worms, flies, and mammals (<xref ref-type="bibr" rid="bib16">Bellen <italic>et al.</italic> 2010</xref>). Similarly, the following sections illustrate elegant examples of what can be learned about human biology from invertebrates and fish. Obviously, not all genes are evolutionarily conserved from invertebrates to human; ∼35% of human genes have no obvious orthologs in flies (<xref ref-type="bibr" rid="bib142">Wangler <italic>et al.</italic> 2015</xref>), but can nevertheless be studied in vertebrates like zebrafish and mice. Indeed, zebrafish allow more robust phenotypic comparisons than flies for organs such as the heart, gut, liver, pancreas, and kidney, and have emerged as a key model system to study processes such as hematopoiesis and neural crest development (<xref ref-type="bibr" rid="bib19">Boatman <italic>et al.</italic> 2013</xref>; <xref ref-type="bibr" rid="bib93">Mayor and Theveneau 2013</xref>).</p>
<p>One consideration when selecting an organism for disease studies is its overall genomic architecture. After the divergence of the human and fly lineages, two rounds of whole genome duplication likely occurred in the last common ancestor to all vertebrates (<xref ref-type="bibr" rid="bib66">Holland <italic>et al.</italic> 1994</xref>; <xref ref-type="bibr" rid="bib37">Dehal and Boore 2005</xref>). As a consequence, humans often have two to four co-orthologs of individual fly genes: for example, four <italic>HOX</italic> gene clusters in humans <italic>vs.</italic> one in flies. According to the principle of subfunctionalization (<xref ref-type="bibr" rid="bib46">Force <italic>et al.</italic> 1999</xref>), the human co-orthologs likely share among them ancestral functions represented by the single-copy fly genes. Likewise, teleosts (majority of bony fish) experienced an additional genome duplication that provided zebrafish with two copies of ∼25% of human genes (<xref ref-type="bibr" rid="bib68">Howe <italic>et al.</italic> 2013</xref>). The direct orthology of zebrafish genes to human orthologs is usually unambiguous (<xref ref-type="bibr" rid="bib21">Braasch <italic>et al.</italic> 2016</xref>), which facilitates connection of zebrafish experimental findings to human biology.</p>
<p>Flies and fish have tissues and organs that are specific to their phyla. One may wonder if wings of flies or dorsal fins in fish can teach us something that is directly relevant to human development or physiology. Mutations that affect the development of wings in flies pioneered the characterization of key developmental pathways such as the Notch (mutants have a “notch” in the wing due to loss of distal wing tissue) and Wingless (Wnt) signaling pathways. Interestingly, pathogenic variants in many genes in the Wnt pathway in humans cause Robinow syndrome—a severe skeletal dysplasia with short stature, short limbs and digits, dysmorphic facial features, and a variety of other problems including cardiac anomalies (MIM# 180700, 268310, 616331, and 616894). Pathogenic variants in <italic>WNT5A</italic> (a homolog of <italic>Drosophila <ext-link ext-link-type="uri" xlink:href="http://flybase.org/reports/FBgn0010194.html">Wnt5</ext-link></italic>) (<xref ref-type="bibr" rid="bib107">Person <italic>et al.</italic> 2010</xref>), its receptor <italic>ROR2</italic> (<xref ref-type="bibr" rid="bib2">Afzal <italic>et al.</italic> 2000</xref>; <xref ref-type="bibr" rid="bib137">van Bokhoven <italic>et al.</italic> 2000</xref>), as well as mutations in signal mediators <italic>DVL1</italic> (<xref ref-type="bibr" rid="bib22">Bunn <italic>et al.</italic> 2015</xref>; <xref ref-type="bibr" rid="bib146">White <italic>et al.</italic> 2015</xref>) and <italic>DVL3</italic> (<xref ref-type="bibr" rid="bib147">White <italic>et al.</italic> 2016</xref>) (homologs of the fly <italic><ext-link ext-link-type="uri" xlink:href="http://flybase.org/reports/FBgn0000499.html">dishevelled</ext-link></italic> gene) cause Robinow syndrome. Thus, although flies do not have an endoskeleton like in vertebrates, conserved genetic machinery that regulates wing patterning in <italic>Drosophila</italic> is responsible for skeletal and craniofacial defects in humans. This parsimony arises because evolutionarily conserved molecular pathways are reused in different cellular contexts and tissues.</p>
<p>These observations led to the concept of “phenologs” or “orthologous phenotypes” (<xref ref-type="bibr" rid="bib95">McGary <italic>et al.</italic> 2011</xref>). Orthologous genes often cause different phenotypes in different species, yet the proteins encoded by these genes have similar molecular functions. To discover phenologs, one can cluster genes known to cause a human disease and determine the phenotypes caused by mutations in the corresponding genes in model organisms. For example, human genes associated with breast cancer overlap with <italic>C. elegans</italic> genes that mutate to cause a high frequency of male offspring. While the phenotypes in humans (breast cancer) and worms (increased male offspring) do not appear related, they derive from common underlying genetic defects (subset of genes involved in DNA damage response). Once these nonobvious relationships are documented, then additional genetic links can be made between models and humans (<xref ref-type="bibr" rid="bib95">McGary <italic>et al.</italic> 2011</xref>). For genes that are evolutionarily conserved, simple model organisms with short generation times and amenable to inexpensive and efficient genetic manipulations can yield rapid insights into basic biological functions through detailed <italic>in vivo</italic> studies (<xref ref-type="bibr" rid="bib81">Lehner 2013</xref>).</p>
<p>Finally, when using one species to understand another, a key experiment is to determine how interchangeable genes are between species if one wishes to assess whether a human variant may be pathogenic. Several studies performed in yeast indicate that many yeast genes (33–47%, depending on the study and assay) can be replaced by their human counterparts (<xref ref-type="bibr" rid="bib59">Hamza <italic>et al.</italic> 2015</xref>; <xref ref-type="bibr" rid="bib72">Kachroo <italic>et al.</italic> 2015</xref>). Many human genes can also significantly or fully rescue fly mutant phenotypes, allowing tests of the effects of human variants on protein function <italic>in vivo</italic>. Although this is based on a biased sample of ∼25 <italic>Drosophila</italic> genes, it suggests that this approach can be productive. One of the most spectacular examples of a cross-species gene rescue is the <italic><ext-link ext-link-type="uri" xlink:href="http://flybase.org/reports/FBgn0010433.html">atonal</ext-link></italic> gene, associated with deafness, blindness, and loss of proprioception in flies as well as in mammals (<xref ref-type="bibr" rid="bib71">Jarman <italic>et al.</italic> 1993</xref>). The fly <italic><ext-link ext-link-type="uri" xlink:href="http://flybase.org/reports/FBgn0010433.html">atonal</ext-link></italic> gene fully rescues loss of the mouse <italic>Atoh1</italic>gene (<xref ref-type="bibr" rid="bib141">Wang <italic>et al.</italic> 2002</xref>). Similarly, the mouse <italic>Atoh1</italic> gene rescues almost all phenotypes associated with the loss of <italic><ext-link ext-link-type="uri" xlink:href="http://flybase.org/reports/FBgn0010433.html">atonal</ext-link></italic> in flies (<xref ref-type="bibr" rid="bib141">Wang <italic>et al.</italic> 2002</xref>). These results are remarkable considering that <italic><ext-link ext-link-type="uri" xlink:href="http://flybase.org/reports/FBgn0010433.html">atonal</ext-link></italic> and <italic>Atoh1</italic> share only a short stretch of sequence similarity in the DNA binding domain, and <ext-link ext-link-type="uri" xlink:href="http://www.flyrnai.org/diopt">most orthology prediction programs</ext-link> do not identify these genes as strong ortholog candidates. We anticipate that, in many cases, testing human genes in model organisms will provide an experimentally productive platform for analysis of gene function, variant pathogenicity, and disease pathogenesis, even when tested in very different biological contexts.</p>
</sec>
<sec id="s2">
<title>Model Organism Studies Can Facilitate Diagnosis and Treatment</title>
<sec id="s3">
<title>Drosophila, TRP channels and a spectrum of Mendelian disorders</title>
<p>One of the earliest examples of a <italic>Drosophila</italic> mutant that informed studies of an extensive gene family implicated in numerous human disorders comes from the fly <italic><ext-link ext-link-type="uri" xlink:href="http://flybase.org/reports/FBgn0003861.html">transient receptor potential</ext-link></italic> (<italic><ext-link ext-link-type="uri" xlink:href="http://flybase.org/reports/FBgn0003861.html">trp</ext-link></italic>) gene. Studies in the 1960s identified a nonphototaxic fly mutant with a distinct electroretinogram phenotype (<xref ref-type="bibr" rid="bib32">Cosens and Manning 1969</xref>). Subsequent studies revealed that the affected gene encodes a pore-forming cation channel that is the founding member of a large, diverse family of evolutionarily conserved proteins known as TRP channels (<xref ref-type="bibr" rid="bib99">Montell 2005</xref>). TRP channel family members have a weak voltage-sensing transmembrane domain, a selectivity filter, and diverse N- and C-terminal domains that provide versatile activation mechanisms. TRP family members encode unique channels that respond to light, sound, chemicals, temperature, pressure, or tactile stimuli, and can integrate multiple signals. The human genome contains 28 TRP channel family members (<xref ref-type="bibr" rid="bib56">Gray <italic>et al.</italic> 2015</xref>), 11 of which are implicated in Mendelian disorders. These disorders have diverse clinical presentations, different inheritance patterns, and affect distinct tissues (<xref ref-type="table" rid="t1">Table 1</xref>). Insights from <italic>Drosophila</italic> led to an understanding of TRP channel function, which laid the groundwork for defining the cause of these disorders as resulting from gain-of-function (GOF), loss-of-function (LOF) or modulation (alteration)-of-function mechanisms. The most extreme disease is caused by <italic>TRPV4</italic> (<xref ref-type="bibr" rid="bib34">Dai <italic>et al.</italic> 2010</xref>)—a gene that underlies a broad spectrum of skeletal and nervous system phenotypes. An autosomal dominant condition <italic>brachyolmias type 3</italic> (MIM# 113500), which is characterized by short trunk, short stature, and scoliosis, as well as a series of more severe skeletal dysplasias, is due to GOF missense mutations in <italic>TRPV4</italic> that causes the channels to be activated by stimuli to which they would not normally respond (<xref ref-type="bibr" rid="bib103">Nishimura <italic>et al.</italic> 2012</xref>). Other variants in <italic>TRPV4</italic> cause <italic>congenital distal spinal muscular atrophy</italic> (MIM# 600175) and <italic>Charcot-Marie-Tooth disease type 2C</italic> (MIM# 606071) (<xref ref-type="bibr" rid="bib38">Deng <italic>et al.</italic> 2010</xref>; <xref ref-type="bibr" rid="bib78">Landoure <italic>et al.</italic> 2010</xref>; <xref ref-type="bibr" rid="bib102">Nilius and Owsianik 2010</xref>). Heterozygous mutations leading to these neurological phenotypes appear to have a complex impact on channel function and appear as GOF or LOF in different assays (<xref ref-type="bibr" rid="bib7">Auer-Grumbach <italic>et al.</italic> 2010</xref>; <xref ref-type="bibr" rid="bib38">Deng <italic>et al.</italic> 2010</xref>; <xref ref-type="bibr" rid="bib78">Landoure <italic>et al.</italic> 2010</xref>). These functional insights would likely be identified more slowly without the mechanistic understanding of the channels provided by studies in <italic>Drosophila</italic>.</p>
<table-wrap id="t1" position="float">
<label>Table 1</label>
<caption>
<title>Select Mendelian disorders from TRP channel family members</title>
</caption>
<table frame="above" rules="groups">
<col span="1" width="12.77%"/>
<col span="1" width="12.45%"/>
<col span="1" width="29.38%"/>
<col span="1" width="19.77%"/>
<col span="1" width="25.63%"/>
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" scope="col" valign="top">Gene Name</th>
<th align="center" colspan="1" rowspan="1" scope="col" valign="top">Inheritance</th>
<th align="center" colspan="1" rowspan="1" scope="col" valign="top">Disorder (MIM#, name)</th>
<th align="center" colspan="1" rowspan="1" scope="col" valign="top">Affected Tissues</th>
<th align="center" colspan="1" rowspan="1" scope="col" valign="top">Proposed Genetic Mechanism</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top">
<italic>MCOLN1</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">AR</td>
<td align="center" colspan="1" rowspan="1" valign="top">#252650, Mucolipidosis IV</td>
<td align="center" colspan="1" rowspan="1" valign="top">Neurologic, ocular, gastrointestinal</td>
<td align="center" colspan="1" rowspan="1" valign="top">LOF</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top">
<italic>TRPM1</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">AR</td>
<td align="center" colspan="1" rowspan="1" valign="top">#613216, Night blindness, congenital stationary (complete), 1C</td>
<td align="center" colspan="1" rowspan="1" valign="top">Photoreceptors</td>
<td align="center" colspan="1" rowspan="1" valign="top">LOF</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top">
<italic>TRPM6</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">AR</td>
<td align="center" colspan="1" rowspan="1" valign="top">#602014, Hypomagnesemia 1, intestinal</td>
<td align="center" colspan="1" rowspan="1" valign="top">Gastrointestinal</td>
<td align="center" colspan="1" rowspan="1" valign="top">LOF</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top">
<italic>PKD2</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">AD</td>
<td align="center" colspan="1" rowspan="1" valign="top">#613095, Polycystic kidney disease 2</td>
<td align="center" colspan="1" rowspan="1" valign="top">Renal</td>
<td align="center" colspan="1" rowspan="1" valign="top">LOF (haploinsufficiency)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top">
<italic>TRPA1</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">AD</td>
<td align="center" colspan="1" rowspan="1" valign="top">#615040, Episodic pain syndrome, familial</td>
<td align="center" colspan="1" rowspan="1" valign="top">Peripheral nervous system</td>
<td align="center" colspan="1" rowspan="1" valign="top">GOF</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top">
<italic>TRPC3</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">AD</td>
<td align="center" colspan="1" rowspan="1" valign="top">#616410, ?Spinocerebellar ataxia 41</td>
<td align="center" colspan="1" rowspan="1" valign="top">Central nervous system</td>
<td align="center" colspan="1" rowspan="1" valign="top">Toxic GOF</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top">
<italic>TRPC6</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">AD</td>
<td align="center" colspan="1" rowspan="1" valign="top">#603965, Glomerulosclerosis, focal segmental, 2</td>
<td align="center" colspan="1" rowspan="1" valign="top">Renal</td>
<td align="center" colspan="1" rowspan="1" valign="top">GOF</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top">
<italic>TRPM4</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">AD</td>
<td align="center" colspan="1" rowspan="1" valign="top">#604559, Progressive familial heart block, type IB</td>
<td align="center" colspan="1" rowspan="1" valign="top">Cardiac</td>
<td align="center" colspan="1" rowspan="1" valign="top">GOF</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top">
<italic>TRPM7</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">AD</td>
<td align="center" colspan="1" rowspan="1" valign="top">#105500, Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility</td>
<td align="center" colspan="1" rowspan="1" valign="top">Central nervous system</td>
<td align="center" colspan="1" rowspan="1" valign="top">Modulation of function?</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" scope="row" valign="top">
<italic>TRPV3</italic>
</td>
<td align="center" colspan="1" rowspan="2" valign="top">AD</td>
<td align="center" colspan="1" rowspan="1" valign="top">#616400, ?palmoplantar keratoderma</td>
<td align="center" colspan="1" rowspan="2" valign="top">Skin</td>
<td align="center" colspan="1" rowspan="2" valign="top">GOF</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" scope="col" valign="top">#614594, Olmsted syndrome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top">
<italic>TRPV4</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">AD</td>
<td align="center" colspan="1" rowspan="1" valign="top">Two spectra of Mendelian disorders- skeletal and neurologic (see text)</td>
<td align="center" colspan="1" rowspan="1" valign="top">Skeletal in one group, neurologic in another group</td>
<td align="center" colspan="1" rowspan="1" valign="top">Complex (see text)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>AR, Autosomal recessive; AD, autosomal dominant; LOF, loss of function; GOF, gain of function.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s4">
<title>Zebrafish and melanoma</title>
<p>Research on zebrafish complements research on flies because zebrafish share vertebrate-specific features with human, such as similar organ structures. Zebrafish offer a number of experimental advantages for investigation of human disease mechanisms and therapeutic strategies (<xref ref-type="bibr" rid="bib109">Phillips and Westerfield 2014</xref>). Chief among these are the ease of genetic manipulation, the ability to replace zebrafish genes with human genes, sensitive phenotypic analyses, and the capacity to conduct high-throughput screens of small molecules for potential therapeutics.</p>
<p>Examples discussed here involve human melanomas, which are genetically diverse cancers. This genetic heterogeneity makes it difficult to discover which gene mutations are primary drivers of oncogenesis, and which are critical modifiers that promote metastatic disease. A valine-to-glutamic acid mutation at position 600 in the human <italic>BRAF</italic> gene is the most frequent mutation driving human melanomas, but mutations in other genes are required for metastasis (<xref ref-type="bibr" rid="bib111">Pollock <italic>et al.</italic> 2003</xref>). In searches for “second hit” loci in <italic>BRAF<sup>V600E</sup></italic> melanomas, a region of chromosome 1q21 was identified as a key driver of metastasis, but the presence of &gt;50 genes in the identified interval made it difficult to determine the primary driver (<xref ref-type="bibr" rid="bib87">Lin <italic>et al.</italic> 2008</xref>). Testing genes in the corresponding zebrafish chromosomal interval revealed a single gene, <italic>SET domain</italic>, <italic>bifurcated 1</italic> (<italic>SETDB1</italic>) that cooperates with <italic>BRAF<sup>V600E</sup></italic> to drive melanoma formation and growth (<xref ref-type="bibr" rid="bib24">Ceol <italic>et al.</italic> 2011</xref>). The 1q21 interval was subsequently linked to familial melanoma in human (<xref ref-type="bibr" rid="bib90">Macgregor <italic>et al.</italic> 2011</xref>), establishing <italic>SETDB1</italic> as a major human melanoma oncogene. A high-throughput chemical screen of these zebrafish with ∼2000 substances identified inhibitors of dihydroorotate dehydrogenase (DHODH), such as the anti-inflammatory drug leflunomide, as suppressors of neural crest development and melanoma formation (<xref ref-type="bibr" rid="bib148">White <italic>et al.</italic> 2011</xref>). This work in zebrafish led to <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/study/NCT01611675">Phase I/II clinical trials of leflunomide in combination with a previously studied BRAF-inhibitor for treatment of melanoma</ext-link>. The ability to create sensitized zebrafish lines with human genes, coupled with the ability to screen thousands of compounds for their capacity to rescue disease phenotypes, illustrates the power of zebrafish studies for illuminating human disease pathogenesis and revealing novel drug targets.</p>
</sec>
</sec>
<sec id="s5">
<title>Model Organisms and Medical Diagnosis</title>
<p>These examples of fly and fish research illustrate the often under-recognized foundational contributions to human health that model organism research provides. Rapid advances in medical technology have expanded the need to incorporate these insights into the practice of medicine. Next-generation sequencing, particularly WES, transformed the diagnosis of rare disease (<xref ref-type="bibr" rid="bib55">Gonzaga-Jauregui <italic>et al.</italic> 2012</xref>; <xref ref-type="bibr" rid="bib152">Yang <italic>et al.</italic> 2014</xref>; <xref ref-type="bibr" rid="bib114">Retterer <italic>et al.</italic> 2016</xref>). Furthermore, the coupling of genomic data with phenotypes extracted from medical electronic health records enables large-scale analysis of the clinical impact of rare variants (<xref ref-type="bibr" rid="bib1">Abul-Husn <italic>et al.</italic> 2016</xref>; <xref ref-type="bibr" rid="bib39">Dewey <italic>et al.</italic> 2016</xref>). However, this new sequencing technology presents challenges. Each personal genome contains hundreds of rare and unique variants that can have dramatic functional significance (<xref ref-type="bibr" rid="bib33">Coventry <italic>et al.</italic> 2010</xref>), but most are without obvious effect. Their sheer number can make interpretation difficult, leaving the majority of individuals with apparent Mendelian diseases undiagnosed (<xref ref-type="bibr" rid="bib101">Need <italic>et al.</italic> 2012</xref>; <xref ref-type="bibr" rid="bib152">Yang <italic>et al.</italic> 2014</xref>; <xref ref-type="bibr" rid="bib112">Posey <italic>et al.</italic> 2016</xref>; <xref ref-type="bibr" rid="bib114">Retterer <italic>et al.</italic> 2016</xref>). Merging results from many genomes has significantly increased the power of sequence analysis, but, at the same time, has dramatically increased the need to study the impact of gene variants on protein function. We argued for an important role of model organism research studies in this effort (<xref ref-type="bibr" rid="bib15">Bellen and Yamamoto 2015</xref>). Here, we present several examples of the early success of this approach.</p>
<sec id="s6">
<title>Centers for Mendelian Genomics</title>
<p>The study of Mendelian disorders has yielded many significant insights into human biology, starting with the recognition of <italic>alkaptonuria</italic> (MIM# 203500) as an example of Mendel’s laws operating in humans (<xref ref-type="bibr" rid="bib52">Garrod 1902</xref>, <xref ref-type="bibr" rid="bib53">1923</xref>). The availability of WES propelled novel disease gene and variant discovery, leading to in-depth cataloging of the function of thousands of genes in the human genome, and providing insights into the mechanisms of both rare Mendelian disease and more common, complex traits (<xref ref-type="bibr" rid="bib3">Albert <italic>et al.</italic> 2007</xref>; <xref ref-type="bibr" rid="bib84">Levy <italic>et al.</italic> 2007</xref>; <xref ref-type="bibr" rid="bib145">Wheeler <italic>et al.</italic> 2008</xref>; <xref ref-type="bibr" rid="bib8">Bainbridge <italic>et al.</italic> 2010</xref>; <xref ref-type="bibr" rid="bib88">Lupski <italic>et al.</italic> 2010</xref>; <xref ref-type="bibr" rid="bib18">Blair <italic>et al.</italic> 2013</xref>; <xref ref-type="bibr" rid="bib149">Wu <italic>et al.</italic> 2015</xref>). Nonetheless, the diagnostic rate (% of cases in which a pathogenic mutation in a known disease gene was identified) of clinical WES remains at 25–30% (<xref ref-type="bibr" rid="bib151">Yang <italic>et al.</italic> 2013</xref>, <xref ref-type="bibr" rid="bib152">2014</xref>; <xref ref-type="bibr" rid="bib80">Lee <italic>et al.</italic> 2014</xref>; <xref ref-type="bibr" rid="bib44">Farwell <italic>et al.</italic> 2015</xref>; <xref ref-type="bibr" rid="bib114">Retterer <italic>et al.</italic> 2016</xref>; <xref ref-type="bibr" rid="bib42">Eldomery <italic>et al.</italic> 2017</xref>; <xref ref-type="bibr" rid="bib144">Wenger <italic>et al.</italic> 2017</xref>). The diagnostic yield varies depending on age and how the patients were selected, with diagnostic rates as high as 57% in infants in a tertiary pediatric center <italic>vs.</italic> 17.5% for adults (<xref ref-type="bibr" rid="bib112">Posey <italic>et al.</italic> 2016</xref>; <xref ref-type="bibr" rid="bib130">Stark <italic>et al.</italic> 2016</xref>). A review of <ext-link ext-link-type="uri" xlink:href="https://www.omim.org/">Online Mendelian Inheritance in Man (OMIM)</ext-link> reveals 8487 human disease phenotypes with suspected Mendelian basis, of which 6017 (70.9%) have a known molecular basis.</p>
<p>For the past 6 years, the National Institutes of Health (NIH) has funded several sequencing centers to use next-generation sequencing techniques, primarily whole-exome sequencing, to identify and describe as many Mendelian disorders as possible (<xref ref-type="bibr" rid="bib10">Bamshad <italic>et al.</italic> 2012</xref>). The first 4 years of funding to three independent <ext-link ext-link-type="uri" xlink:href="http://mendelian.org/">CMGs</ext-link> (Baylor Hopkins CMG, University of Washington CMG, and Yale CMG) produced discoveries of 956 genes, including 375 not previously associated with human disease (<xref ref-type="bibr" rid="bib28">Chong <italic>et al.</italic> 2015</xref>). The overarching approach of the CMGs is to identify individuals, families, and cohorts with conditions that have a high probability of being Mendelian, and to apply WES to identify potentially causative disease genes and variants. The CMGs benefitted significantly from development of several computational tools that enable disease gene and variant identification, phenotype-driven analysis, and identification of clinicians and researchers studying the same gene or phenotype (<xref ref-type="table" rid="t2">Table 2</xref>). One tool essential for the development of these and other studies is <ext-link ext-link-type="uri" xlink:href="https://genematcher.org/">GeneMatcher</ext-link>. By allowing researchers to identify each other based on their interest in a gene, GeneMatcher is an active collaboration tool in human genetics. Importantly, this tool also allows model organism researchers to identify human geneticists and clinicians interested in collaborations (<xref ref-type="bibr" rid="bib128">Sobreira <italic>et al.</italic> 2015b</xref>).</p>
<table-wrap id="t2" position="float">
<label>Table 2</label>
<caption>
<title>Bioinformatic tools and databases developed by the Centers for Mendelian Genomics</title>
</caption>
<table frame="hsides" rules="groups">
<col span="1" width="22.49%"/>
<col span="1" width="23.07%"/>
<col span="1" width="23.07%"/>
<col span="1" width="18.72%"/>
<col span="1" width="12.65%"/>
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" scope="col" valign="top">Function</th>
<th align="center" colspan="1" rowspan="1" scope="col" valign="top">Name</th>
<th align="center" colspan="1" rowspan="1" scope="col" valign="top">Description</th>
<th align="center" colspan="1" rowspan="1" scope="col" valign="top">Interface for Fly Researchers</th>
<th align="center" colspan="1" rowspan="1" scope="col" valign="top">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top">Variant identification</td>
<td align="center" colspan="1" rowspan="1" valign="top">HMZDelFinder</td>
<td align="center" colspan="1" rowspan="1" valign="top">Identification of homozygous and hemizygous deletions from exome variant data</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="bib49">Gambin <italic>et al.</italic> (2017)</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top">Variant identification</td>
<td align="center" colspan="1" rowspan="1" valign="top">DNMfinder</td>
<td align="center" colspan="1" rowspan="1" valign="top">Identification of <italic>de novo</italic> variants from trio-WES data</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="bib42">Eldomery <italic>et al.</italic> (2017)</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top">Phenotype database/analysis</td>
<td align="center" colspan="1" rowspan="1" valign="top">PhenoDB <ext-link ext-link-type="uri" xlink:href="https://www.mendeliangenomics.org/">https://www.mendeliangenomics.org/</ext-link></td>
<td align="center" colspan="1" rowspan="1" valign="top">Searchable database of clinical phenotypes for individuals and their relatives, phenotypes reported by expert clinicians</td>
<td align="center" colspan="1" rowspan="1" valign="top">Rapid identification of patients with phenotypes of potential interest for further study</td>
<td align="center" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="bib58">Hamosh <italic>et al.</italic> (2013)</xref>, <xref ref-type="bibr" rid="bib127">Sobreira <italic>et al.</italic> (2015a)</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top">Phenotype database/analysis</td>
<td align="center" colspan="1" rowspan="1" valign="top">OMIMExplorer <ext-link ext-link-type="uri" xlink:href="https://omimexplorer.research.bcm.edu/">https://omimexplorer.research.bcm.edu/</ext-link></td>
<td align="center" colspan="1" rowspan="1" valign="top">Prioritization of exome variants based on clinical phenotype data</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="bib70">James <italic>et al.</italic> (2016)</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top">Phenotype database/analysis</td>
<td align="center" colspan="1" rowspan="1" valign="top">Geno2MP <ext-link ext-link-type="uri" xlink:href="http://geno2mp.gs.washington.edu/Geno2MP">http://geno2mp.gs.washington.edu/Geno2MP</ext-link></td>
<td align="center" colspan="1" rowspan="1" valign="top">Searchable database of genotype and phenotype data</td>
<td align="center" colspan="1" rowspan="1" valign="top">Gene and variant-based searching allows identification of related human phenotypes</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="bib29">Chong <italic>et al.</italic> (2016a)</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top">Gene and/or phenotype matching</td>
<td align="center" colspan="1" rowspan="1" valign="top">GeneMatcher <ext-link ext-link-type="uri" xlink:href="https://genematcher.org/">https://genematcher.org/</ext-link></td>
<td align="center" colspan="1" rowspan="1" valign="top">Identification of collaborators studying the same gene and/or phenotype, functions as a MME node</td>
<td align="center" colspan="1" rowspan="1" valign="top">Identification of physicians and/or scientists who may have study patients with a relevant genotype or phenotype</td>
<td align="center" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="bib127">Sobreira <italic>et al.</italic> (2015a</xref>,<xref ref-type="bibr" rid="bib128">b</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top">Gene and/or phenotype matching</td>
<td align="center" colspan="1" rowspan="1" valign="top">MyGene2 <ext-link ext-link-type="uri" xlink:href="http://www.mygene2.org/">http://www.mygene2.org/</ext-link></td>
<td align="center" colspan="1" rowspan="1" valign="top">Phenotype and genotype database that includes patient-entered data, supports data matching, functions as a MME node</td>
<td align="center" colspan="1" rowspan="1" valign="top">Identification of physicians and/or scientists who may have study patients with a relevant genotype or phenotype</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="bib30">Chong <italic>et al.</italic> (2016b)</xref>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The potential power of integrating model organism studies into interrogations of the functions of candidate disease genes and variants identified by the CMG is illustrated by the analysis of human homologs of a set of 153 <italic>Drosophila</italic> genes required for nervous system development or function (<xref ref-type="bibr" rid="bib150">Yamamoto <italic>et al.</italic> 2014</xref>). For ∼30% of these, a human disease had already been associated with the homologs of the <italic>Drosophila</italic> gene. Interrogation of exome variant data from human homologs of the 153 <italic>Drosophila</italic> genes led to molecular diagnoses in six families. In one example variants in a known disease gene for early onset retinal disease (<italic>CRX</italic>), caused a later onset retinal phenotype not previously seen with <italic>CRX</italic> variants. Such a finding is often referred to as a “phenotypic expansion” of a known disease-linked gene. In another example, a novel disease gene whose biological function was poorly characterized (<italic>ANKLE2</italic>) was discovered to be linked to <italic>autosomal recessive primary microcephaly 16</italic> (MIM# 616681). Within 2 years of the publication of the screen of these 153 fly genes, an additional ∼15% of the genes have become linked to Mendelian diseases. A key insight from this study led to the realization that essential genes in <italic>Drosophila</italic> with more than one human homolog are eight times more likely to be associated with Mendelian diseases, allowing the prioritization of disease candidate genes (<xref ref-type="bibr" rid="bib150">Yamamoto <italic>et al.</italic> 2014</xref>).</p>
<p>There are now several additional examples of novel disease-gene discoveries by the CMG that benefited from collaborative functional studies in <italic>Drosophila</italic>. These include: <italic>metabolic encephalomyopathic crises</italic>, <italic>recurrent</italic>, <italic>with rhabdomyolysis</italic>, <italic>cardiac arrhythmias</italic>, <italic>and neurodegeneration</italic> (MIM# 616878) and <italic>TANGO2</italic> (<xref ref-type="bibr" rid="bib11">Bard <italic>et al.</italic> 2006</xref>; <xref ref-type="bibr" rid="bib75">Kremer <italic>et al.</italic> 2016</xref>; <xref ref-type="bibr" rid="bib77">Lalani <italic>et al.</italic> 2016</xref>); <italic>cerebellar atrophy</italic>, <italic>visual impairment</italic>, <italic>and psychomotor retardation</italic> (MIM# 616875) and <italic>EMC1</italic> (<xref ref-type="bibr" rid="bib60">Harel <italic>et al.</italic> 2016a</xref>); <italic>Harel-Yoon syndrome</italic> (MIM# 617183) and <italic>ATAD3A</italic> (<xref ref-type="bibr" rid="bib61">Harel <italic>et al.</italic> 2016b</xref>); <italic>lissencephaly 6 with microcephaly</italic> (MIM# 616212) and <italic>KATNB1</italic> (<xref ref-type="bibr" rid="bib97">Mishra-Gorur <italic>et al.</italic> 2014</xref>); <italic>steroid-resistant nephrotic syndrome</italic> (MIM# 615573) and <italic>ADCK4</italic> (<xref ref-type="bibr" rid="bib6">Ashraf <italic>et al.</italic> 2013</xref>); and <italic>NRD1</italic> and <italic>OGDHL</italic> as novel disease genes associated with nervous system phenotypes (<xref ref-type="bibr" rid="bib150">Yamamoto <italic>et al.</italic> 2014</xref>; <xref ref-type="bibr" rid="bib153">Yoon <italic>et al.</italic> 2017</xref>). A key characteristic of these efforts is the bidirectional impact of insights: candidate genes identified from sequencing human patients can be studied with reverse genetics in flies, and orthologs of essential <italic>Drosophila</italic> genes can be examined in human genomic data. These bidirectional approaches provide a synergistic effect (<xref ref-type="fig" rid="fig1">Figure 1</xref>) (<xref ref-type="bibr" rid="bib142">Wangler <italic>et al.</italic> 2015</xref>).</p>
<p>Studies of other model organisms also support novel disease gene discovery efforts. For example, the discovery of an association between variation in <italic>FAT1</italic> and a human phenotype of steroid-resistant nephropathy with neurologic involvement benefitted from studies in zebrafish and mice, demonstrating that loss of Fat1 leads to abnormal podocyte and brain development (<xref ref-type="bibr" rid="bib31">Ciani <italic>et al.</italic> 2003</xref>; <xref ref-type="bibr" rid="bib124">Skouloudaki <italic>et al.</italic> 2009</xref>; <xref ref-type="bibr" rid="bib54">Gee <italic>et al.</italic> 2016</xref>). Both organisms also contributed to the identification of additional genes associated with abnormal brain structure or function, such as <italic>CLP1</italic> in <italic>pontocerebellar hypoplasia</italic> (MIM# 615803) (<xref ref-type="bibr" rid="bib74">Karaca <italic>et al.</italic> 2014</xref>; <xref ref-type="bibr" rid="bib120">Schaffer <italic>et al.</italic> 2014</xref>), <italic>KATNB1</italic> in <italic>lissencephaly 6 with microcephaly</italic> (MIM# 616212) (<xref ref-type="bibr" rid="bib97">Mishra-Gorur <italic>et al.</italic> 2014</xref>), and <italic>FMN2</italic> in <italic>nonsyndromic intellectual disability</italic> (MIM# 616193) (<xref ref-type="bibr" rid="bib79">Law <italic>et al.</italic> 2014</xref>). Both organisms also proved useful in the study of non-neurologic phenotypes, such as the role of <italic>ZSWIM6</italic> in <italic>acromelic frontonasal dysostosis</italic> (MIM# 603671) (<xref ref-type="bibr" rid="bib126">Smith <italic>et al.</italic> 2014</xref>), <italic>CAV1</italic>, and <italic>neonatal lipodystrophy</italic> (<xref ref-type="bibr" rid="bib51">Garg <italic>et al.</italic> 2015</xref>), <italic>WDPCP</italic> (MIM# 217085 and 615992) and <italic>INTU</italic> in <italic>ciliopathy syndromes</italic> (<xref ref-type="bibr" rid="bib135">Toriyama <italic>et al.</italic> 2016</xref>), and <italic>FOXE</italic> in <italic>thoracic aortic aneurysms and dissections</italic> (<xref ref-type="bibr" rid="bib76">Kuang <italic>et al.</italic> 2016</xref>).</p>
</sec>
<sec id="s7">
<title>Undiagnosed diseases program and network</title>
<p>Patients with a rare disease often remain undiagnosed or misdiagnosed for years (<xref ref-type="bibr" rid="bib92">Markello <italic>et al.</italic> 2011</xref>). The “diagnostic odyssey” experienced by many of these patients is an emotional and financial burden to patients, families, and the healthcare system. Addressing this problem was part of the motivation for the establishment of the Undiagnosed Diseases Program (UDP), a NIH intramural program led by the NHGRI (National Human Genome Research Institute) (<xref ref-type="bibr" rid="bib47">Gahl <italic>et al.</italic> 2012</xref>). The UDP model is unique for several reasons. First, the patient is the applicant and the patient’s participation drives the process, which is in contrast to most other clinical studies in which referring physicians are the primary applicants. Second, the study starts with a broad and in-depth clinical evaluation. Third, this model of systematic and tailored clinical phenotyping for single, unique cases is followed by genomic assessments using the latest technologies. By accepting applications from individuals with diverse undiagnosed conditions, sorting through thousands of applications to identify patients with strong objective findings, performing extensive phenotyping and clinical testing on accepted patients at the NIH Clinical Center, and performing WES in the majority of the cases, the UDP is able to provide diagnoses for patients and families who have exhausted traditional diagnostic modalities (<xref ref-type="bibr" rid="bib134">Tifft and Adams 2014</xref>). Successes include the description of new disease genes, such as <italic>NT5E</italic> in arterial calcifications (<xref ref-type="bibr" rid="bib129">St Hilaire <italic>et al.</italic> 2011</xref>). The genetic definition of this rare condition implicated adenosine metabolism in more common cases of vascular pathology (<xref ref-type="bibr" rid="bib92">Markello <italic>et al.</italic> 2011</xref>). In addition, the effort has uncovered cases of known conditions that were missed because of misleading laboratory data or unusual phenotypic features that obscured the diagnosis (<xref ref-type="bibr" rid="bib47">Gahl <italic>et al.</italic> 2012</xref>), and revealed “phenotypic expansion” for disease genes such as <italic>AFG3L2</italic> (<xref ref-type="bibr" rid="bib110">Pierson <italic>et al.</italic> 2011</xref>). These efforts are valuable for the medical care of patients, and provide a better understanding of the unanticipated functions of genes.</p>
<p>The successes of the UDP continued after expansion to the UDN (<xref ref-type="bibr" rid="bib48">Gahl <italic>et al.</italic> 2016</xref>; <xref ref-type="bibr" rid="bib113">Ramoni <italic>et al.</italic> 2017</xref>). The <ext-link ext-link-type="uri" xlink:href="https://undiagnosed.hms.harvard.edu/">UDN</ext-link> follows a similar strategy as the UDP but is decentralized and involves seven Clinical Sites [Stanford Medicine, UCLA School of Medicine, Baylor College of Medicine (BCM) with Texas Children’s Hospital, Vanderbilt University Medical Center, Duke Medicine with Columbia University Medical Center, Harvard Teaching Hospitals (Boston Children’s Hospital, Brigham and Women’s Hospital, Massachusetts General Hospital) and NIH], two Sequencing <italic>Cores</italic> (BCM, HudsonAlpha with Illumina), one Model Organisms Screening Center (MOSC, BCM with University of Oregon), one Metabolomics Core (Pacific Northwest National Laboratory with Oregon Health &amp; Science University), and one Coordination Center (Harvard Medical School) (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Recent discoveries by the UDN provided key insights into phenotypic expansion of <italic>NR5A1</italic> in human sex determination (<xref ref-type="bibr" rid="bib12">Bashamboo <italic>et al.</italic> 2016</xref>), <italic>ASXL2</italic> and <italic>Shashi-Pena syndrome</italic> (MIM# 617190) (<xref ref-type="bibr" rid="bib123">Shashi <italic>et al.</italic> 2016</xref>), and <italic>EBF3</italic> and <italic>hypotoia</italic>, <italic>ataxia and delayed development syndrome</italic> (MIM# 617330) (<xref ref-type="bibr" rid="bib25">Chao <italic>et al.</italic> 2017a</xref>), a gene discovery that was also made simultaneously by the CMG and the Deciphering Developmental Disorders Study (DDDS) (<xref ref-type="bibr" rid="bib62">Harms <italic>et al.</italic> 2017</xref>; <xref ref-type="bibr" rid="bib125">Sleven <italic>et al.</italic> 2017</xref>). Use of WES, and, more recently, whole-genome sequencing (WGS) by the UDP and UDN are key in providing diagnostic results for patients who would have remained undiagnosed.</p>
<fig fig-type="figure" id="fig2" position="float">
<label>Figure 2</label>
<caption>
<p>The workflow of the UDN and MOSC. Patients with undiagnosed conditions apply to the UDN primarily through a website (UDN Gateway) that is hosted by the Coordinating Center. Application forms and past medical records are then screened by a case review committee to identify cases with objective findings. Once a patient is accepted, she/he will receive a clinical workup in one of the Clinical Sites. For most cases, WES or WGS are performed on the patient and immediate relatives by one of the two Sequencing Cores. In addition, untargeted metabolomics may be performed on patient samples by the Metabolomics Core. By combining the phenotype and genotype information, some cases can be solved without further investigation. If a diagnosis is not made, the clinical site submits candidate gene/variant information to the MOSC together with a brief description of the patient’s condition. The MOSC first performs a database search using the MARRVEL tool to aggregate existing information on the human gene/variant and its model organism orthologs. In addition, matchmaking with patients in other disease cohorts are attempted through collaborations to identify other individuals with similar genotype and phenotype. Once a variant is considered to be a high priority candidate, experiments to assess gene and variant function are designed by the MOSC investigators and pursued in the <italic>Drosophila</italic> Core or in the Zebrafish Core.</p>
</caption>
<graphic xlink:href="9fig2"></graphic>
</fig>
<p>Given its approach as a network providing in-depth clinical evaluation for the most difficult to diagnose cases, the UDN faces several challenges. For example, genomic discovery in single patients is dramatically hampered by the lack of statistical power. In this context, the need for the UDN to functionally validate candidate gene variants is paramount. Therefore, extensive phenotyping (performed by the Clinical Sites and Metabolomics Core), precise genotyping (performed by the Sequencing Cores), functional exploration of candidate genes and variants (performed by the MOSC) and integration of this information (performed by the Coordination Center) are all key aspects of such a patient-centered effort.</p>
<p>The overall strategy, work flow and some of the key features of the UDN MOSC are highlighted in <xref ref-type="fig" rid="fig2">Figure 2</xref>. The MOSC receives variants submitted by the UDN Clinical Sites. Each Clinical Site integrates genotype and extensive phenotype information to prioritize candidate variants. The MOSC investigators communicate closely with the primary UDN physicians who evaluated the patient, and this dialogue continues throughout the process of investigation. The first step of the MOSC pipeline is to utilize databases to prioritize or filter candidate genomic variants. This quality control step is crucial for the MOSC to confirm that the submitted variant has a high chance of being pathogenic prior to designing and performing the actual experiments in model organisms. Public human exome and genome sequences of individuals who lack severe early-onset Mendelian disorders, such as those in the <ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/">ExAC (Exome Aggregation Consortium) browser</ext-link> (<xref ref-type="bibr" rid="bib82">Lek <italic>et al.</italic> 2016</xref>), are cross-referenced to the genes and variants from UDN patients. The rationale is that, if a similar genotype is found in people without the disease phenotype, it is unlikely that variant of interest in a candidate gene is responsible for the patient’s phenotype. However, one needs to be cautious that this filtration may not be possible for adult onset diseases if the variant in the population genomics databases are from younger individuals that may go on to develop the same disease at a later time point in life. Next, additional human databases with Mendelian disorders, including WES data from the CMG, are studied to identify candidate gene or variant matches. Using this strategy of database integration, the UDN MOSC recently aided in the diagnosis of a previously undiagnosed developmental syndrome (<xref ref-type="bibr" rid="bib121">Schoch <italic>et al.</italic> 2017</xref>). From the WES data of a patient in the UDN with a sporadic phenotype of infantile epilepsy, cataracts, and developmental delay, the Duke Clinical Site identified a <italic>de novo</italic> missense variant in the <italic>nucleus accumbens associated 1</italic> (<italic>NACC1</italic>) gene as one of several candidates for the child’s disorder. Very little gene and protein function information was available to aid in determining whether the <italic>NACC1</italic> variant might be disease-causing. Working with the MOSC, a resulting collaboration between the UDN and the CMG, posting of the gene on <ext-link ext-link-type="uri" xlink:href="https://genematcher.org/">GeneMatcher</ext-link>, and identification of additional cases in clinical laboratories including Baylor Genetics and UCLA Clinical Genomics Center, demonstrated a clear role for this <italic>de novo</italic> variant in the patient’s phenotype. The combined data of these efforts led from the initial “<italic>n</italic> = 1” to identification of a total of seven individuals from seven independent families, all with the same <italic>de novo</italic> missense variant in <italic>NACC1</italic> and presenting with the same disease phenotypes (<xref ref-type="bibr" rid="bib121">Schoch <italic>et al.</italic> 2017</xref>). In this case, the presence of a unique variant and a unique phenotype made collaboration and matchmaking between studies and centers the key to discovery, and model organism studies were not necessary to prove the causality of this <italic>de novo</italic> variant. Nevertheless, this example clearly illustrates how the prescreening step prior to experimentation in model organisms can be productive. In addition, having the ability to interface with physicians and other scientists, through GeneMatcher and other matchmaking efforts, will allow model organism researchers to contribute to the diagnosis prior to the actual model organism work.</p>
<p>After searching for additional cases, the MOSC uses model organism databases including yeast, worm, fly, fish, and rodents to understand the extent to which the gene is conserved, where and when the gene is expressed, what the loss of function phenotypes are, whether the site of the candidate human pathogenic variant is conserved within the orthologous proteins of model organisms, and what tools and reagents have already been generated to study the gene. A recently developed web-based tool named <ext-link ext-link-type="uri" xlink:href="http://marrvel.org/">MARRVEL (Model organism Aggregated Resources for Rare Variant ExpLoration)</ext-link> automates most of these searches and allows anyone to quickly retrieve the relevant information in a simple comprehensive format (<xref ref-type="bibr" rid="bib140">Wang <italic>et al.</italic> 2017</xref>).</p>
<p>Next, genes are assigned to the <italic>Drosophila</italic> or Zebrafish Core facilities, where the genes and variants from the UDN patients are studied for their functional impact, to provide a better understanding of the relationships among the gene, variant, and disease phenotypes (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Genes that are conserved in <italic>Drosophila</italic> (∼65% of human genes) are assigned to the <italic>Drosophila</italic> Core, and the remaining (∼35%) genes are assigned to the Zebrafish Core. Occasionally, variants identified in diseases that affect vertebrate specific organ systems such as bone and neural crest derived structures are also assigned to the fish core.</p>
<p>In the <italic>Drosophila</italic> Core, experiments are tailored to each gene and variant using diverse genetic strategies. One strategy depends on the versatile engineered transposable element, MiMIC (<italic>Minos</italic>-mediated integration cassette) (<xref ref-type="bibr" rid="bib139">Venken <italic>et al.</italic> 2011</xref>), which allows “humanization” of <italic>Drosophila</italic> genes (<xref ref-type="bibr" rid="bib15">Bellen and Yamamoto 2015</xref>) (<xref ref-type="fig" rid="fig3">Figure 3</xref>). This pipeline allows for: (1) generation of strong LOF alleles in the fly gene of interest; (2) expression of the yeast GAL4 transcription factor driven by endogenous enhancers of the gene of interest; (3) functional replacement of the fly gene with the reference (wild-type) human gene to test for rescue of the fly mutant phenotype with the orthologous reference human cDNA expressed under control of a GAL4 expressed in the proper spatial and temporal pattern; and (4) variant function analysis through expression of the human disease allele variant in the same fly line. Other strategies are also used because different reagents (<italic>e.g.</italic>, well characterized LOF alleles, experimentally verified RNAi lines) may be available or rescue with human cDNA may not always be successful (<xref ref-type="bibr" rid="bib61">Harel <italic>et al.</italic> 2016b</xref>).</p>
<fig fig-type="figure" id="fig3" position="float">
<label>Figure 3</label>
<caption>
<p>Strategy to “humanize” a <italic>Drosophila</italic> gene to assess functional consequences of a novel variant. (A) For most genes, the <italic>Drosophila</italic> Core of the MOSC performs functional studies of a patient variant by humanizing the orthologous gene in the fly. First, a fly gene that is most likely to be the ortholog of the human gene is identified using the MARRVEL tool. MARRVEL also provides a link to the FlyBase page that displays known biological function, transcriptomics and proteomics data, mutant phenotypes and available resources for the <italic>Drosophila</italic> gene of interest. If a coding intronic MiMIC is available, the <italic>Drosophila</italic> Core uses this as an entry point to study the gene. Through recombinase-mediated cassette exchange (RMCE), an artificial exon is integrated that functions as a gene trap, creating a strong LOF allele. This artificial exon contains a T2A ribosomal skipping sequence and a coding sequence for the GAL4 transcriptional activator (T2A-GAL4). (B) By crossing the T2A-GAL4 strain to a transgenic fly that carries a UAS-human cDNA construct (together with a deficiency of the locus or an independent mutant allele of the fly gene, data not shown), the fly gene can be humanized. When the gene of interest is transcribed, the splice acceptor (SA) in the artificial exon splices into the upstream exon. Since a transcription termination sequence (polyA) is present at the 3′ end of this artificial exon, the transcript is terminated, and the remaining portion of the fly gene is not transcribed. When this transcript is translated, a truncated protein that is usually nonfunctional is made together with a GAL4 protein. GAL4 is expressed in the same spatial and temporal pattern as the fly gene, allowing expression of the corresponding human cDNA under the control of the UAS element (GAL4 target sequence). By comparing the ability of the reference (wild type) and variant (mutant) to rescue the fly mutant phenotype, one can assess whether the variant of interest impacts protein function.</p>
</caption>
<graphic xlink:href="9fig3"></graphic>
</fig>
<p>In the Zebrafish Core, CRISPR/Cas9 gene editing technology is used to target mutations into the orthologous gene and to LOF alleles in regions of the gene encoding critical functions, such as DNA binding domains, protein interaction domains, or enzymatic catalytic sites. The Zebrafish Core injects CRISPR guide RNAs (gRNAs) and Cas9 mRNA or protein into one-cell zebrafish embryos, where gene editing occurs during early cleavage divisions of the embryo. This results in large clones of mutant cells, several of which almost invariably enter the germline. To increase throughput, the Core combines multiple gRNAs targeting different genes in the same injection (<xref ref-type="bibr" rid="bib122">Shah <italic>et al.</italic> 2015</xref>). This multiplexing strategy reduces the number of animals to be raised because each individual carries mutations in multiple genes. After using PCR to genotype adults developed from injected embryos, recovering mutant alleles after outcrosses, and separating mutant lines in subsequent generations, the Zebrafish Core applies a wide range of assays to characterize mutant phenotypes. Phenotypic features found in the zebrafish mutants are compared to the patients’ clinical features, and investigations to study the underlying pathobiology are initiated. Subsequent rescue experiments with wild-type and variant cDNAs or mRNAs can validate the pathogenicity of the variants.</p>
<p>Through these strategies, the UDN MOSC recently aided the identification of novel cases and the functional validation of <italic>de novo</italic> variants in <italic>EBF3</italic> using <italic>Drosophila</italic> (<xref ref-type="bibr" rid="bib25">Chao <italic>et al.</italic> 2017a</xref>). Starting with a case from the UDP of a child with a neurodevelopmental disorder with a <italic>de novo</italic> variant of unknown significance in <italic>EBF3</italic> (<italic>Early B-Cell Factor 3</italic>), the MOSC identified two additional patients with <italic>de novo</italic> variants altering the same amino acid of the EBF3 protein through collaborative database searches. In addition, using a MiMIC insertion line in the fly <italic>EBF3</italic> ortholog <italic><ext-link ext-link-type="uri" xlink:href="http://flybase.org/reports/FBgn0001319.html">knot</ext-link></italic>—a gene that was well-studied in the context of neural development—the MOSC showed that a reference human <italic>EBF3</italic> cDNA can rescue the lethality of the fly <italic><ext-link ext-link-type="uri" xlink:href="http://flybase.org/reports/FBgn0001319.html">knot</ext-link></italic> LOF mutation, showing that human <italic>EBF3</italic> can functionally replace the <italic>Drosophila</italic> ortholog. The missense <italic>de novo</italic> variants found in the patient abolished the ability of human <italic>EBF3</italic> to rescue mutant flies (<xref ref-type="bibr" rid="bib25">Chao <italic>et al.</italic> 2017a</xref>). Combined with <italic>in vitro</italic> studies, this work provided clear evidence that the <italic>EBF3 de novo</italic> variants are pathogenic in the three cases. Both statistical human genetic evidence and the fly functional analysis support this conclusion (<xref ref-type="bibr" rid="bib25">Chao <italic>et al.</italic> 2017a</xref>). In parallel, two other groups simultaneously provided additional cases of <italic>EBF3 de novo</italic> variants (<xref ref-type="bibr" rid="bib62">Harms <italic>et al.</italic> 2017</xref>; <xref ref-type="bibr" rid="bib125">Sleven <italic>et al.</italic> 2017</xref>). This study is the first to demonstrate the effectiveness of the MOSC pipeline in variant validation for the UDN.</p>
</sec>
<sec id="s8">
<title>The Canadian RDMM network</title>
<p>In Canada, a series of rare disease gene discovery projects, including FORGE (Finding of Rare Disease Genes) (<xref ref-type="bibr" rid="bib14">Beaulieu <italic>et al.</italic> 2014</xref>), Care4Rare (<xref ref-type="bibr" rid="bib118">Sawyer <italic>et al.</italic> 2016</xref>), IGNITE (Identifying Genes and Novel Therapeutics to Enhance Treatment), Omics2TreatID (<xref ref-type="bibr" rid="bib132">Tarailo-Graovac <italic>et al.</italic> 2016</xref>), and TIDE BC (<xref ref-type="bibr" rid="bib119">Sayson <italic>et al.</italic> 2015</xref>; <xref ref-type="bibr" rid="bib132">Tarailo-Graovac <italic>et al.</italic> 2016</xref>), led to the identification of &gt;300 disease genes over the past 5 years. A complementary national project was established to expedite collaboration between basic scientists and clinicians for model organism-based functional studies of rare disease gene variants, and for the development of new therapeutic strategies using model systems. The <ext-link ext-link-type="uri" xlink:href="http://www.rare-diseases-catalyst-network.ca/">RDMM</ext-link> connects Canada’s disease gene discovery projects with the Canadian model organism communities of yeast, <italic>C. elegans</italic>, <italic>Drosophila</italic>, zebrafish, and mouse (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Collaborations are established between clinicians and basic researchers as soon as possible after the initial identification of candidate genes, and a rapid response seed grant is awarded to support immediate functional experiments—a unique feature of the RDMM. The anticipated outcomes are: (1) elucidation of gene function and functional validation of human genetic variants that cause disease; (2) high impact publications of disease gene discoveries through inclusion of functional data; (3) potential rationale for treatment (<italic>e.g.</italic>, identification of candidate drug targets) via knowledge of a disease gene pathway; and (4) establishment of longer term collaborations between basic scientists and clinicians that will lead to basic or applied research.</p>
<fig fig-type="figure" id="fig4" position="float">
<label>Figure 4</label>
<caption>
<p>The workflow of the Canadian RDMM Network. RDMM connects Canada’s disease gene discovery projects with the Canadian model organism researchers. Investigators that work with yeast, <italic>C. elegans</italic>, <italic>Drosophila</italic>, zebrafish, or mouse are encouraged to join the network. Upon registration, the investigator provides a list of genes or genetic pathways in which they are experts. In parallel, a physician or a human geneticist submits a “connect application” for cases that they wish to find a model organism collaborator for. If the case is approved by the Clinical Advisory Committee, the Scientific Advisory Committee performs a search of the model organism registry and identifies an investigator that specializes in the orthologous gene. Upon matchmaking, the model organism investigator and the physician/human geneticist discuss a working plan and submit a proposal to the Scientific Advisory Committee. If the case is approved, funding is provided (1 year, Can$25,000) to generate a disease model and study the candidate gene/variant. The long-term goal of this process is to connect clinicians and basic researchers to establish a collaborative network across the country to facilitate rare disease research.</p>
</caption>
<graphic xlink:href="9fig4"></graphic>
</fig>
<p>Using the RDMM infrastructure, a clinician or an investigator in a genetics laboratory who identifies a new candidate gene can submit a “connect application” (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Connect applications can also be submitted by a clinical researcher who wants to propose a model organism project for a known disease gene but for which pathophysiological understanding or treatment options are lacking. The Clinical Advisory Committee evaluates these applications within 2 weeks, and, if approved, the network registry is searched for potential orthologous gene matches that identify a model organism researcher who is an expert on the gene of interest. To generate this registry, all investigators working with model organisms in Canada were encouraged to establish an RDMM account and submit genes they designate as tier 1, 2, or 3 depending on the researcher’s level of expertise and availability of models in their laboratory. Selected investigators are invited to write a short “catalyst grant proposal application” on how the researcher would assess the functional consequences of mutations. The intention is to rapidly identify researchers who have a history and track record of studying the function of orthologs of rare disease-linked genes. Ideally, the selected individual is poised to immediately conduct functional analyses that will provide new biological insight into a human disease gene. The model organism investigator is given a year to generate a model and provide a report with the collaborating clinician. The goal of this process is not only to validate candidate genes, investigate known disease genes, and generate models to test possible drugs, but also to facilitate links between clinicians and basic researchers to create collaborative networks that will lead to larger projects.</p>
<p>To date, over 400 model organism researchers have registered in the database, entered over 5800 genes of interest, and 46 catalyst grants were funded since January 2015. RDMM-funded projects already led to identification of <italic>NANS deficiency</italic> (MIM# 610442) (<xref ref-type="bibr" rid="bib138">van Karnebeek <italic>et al.</italic> 2016</xref>)—a condition with skeletal dysplasia and developmental delay caused by insufficient sialic acid synthesis. Knockdown of the orthologous zebrafish <italic>nansa</italic> gene, encoding sialic acid synthase, in embryos resulted in abnormal skeletal development similar to the patients’ phenotype. This phenotype in zebrafish mutants was partially rescued by the addition of sialic acid to the culture water, opening the door to potential treatment with oral sialic acid in human patients. Another example is the identification and characterization of a dominant mutation in <italic>NALCN</italic>, which encodes a cation channel, causing intellectual disability, ataxia, and arthrogryposis (<xref ref-type="bibr" rid="bib5">Aoyagi <italic>et al.</italic> 2015</xref>)—a gene previously associated only with a recessive condition with developmental delay and hypotonia (MIM# 615419). Introduction of the analogous variant into the <italic>C. elegans</italic> homolog <italic>nca-1</italic> induced a dominant GOF neurological phenotype, providing evidence that the disease-linked variant likely has a similar impact on the human NALCN protein.</p>
</sec>
<sec id="s9">
<title>Facilitating international collaboration through rare and undiagnosed disease research consortia</title>
<p>A number of institutes and organizations around the world are actively engaged in undiagnosed rare diseases research: Japan [<ext-link ext-link-type="uri" xlink:href="http://www.amed.go.jp/en/program/IRUD/">Initiative on Rare and Undiagnosed Diseases (IRUD)</ext-link>]; Italy (<ext-link ext-link-type="uri" xlink:href="http://www.telethon.it/node/49281">Telethon Undiagnosed Diseases Program</ext-link>); and Australia and New Zealand [Undiagnosed Diseases Program—Australia and New Zealand (<xref ref-type="bibr" rid="bib13">Baynam <italic>et al.</italic> 2017</xref>)]. Recent establishment of large international consortia, such as the <ext-link ext-link-type="uri" xlink:href="http://www.udninternational.org/">Undiagnosed Diseases Network International (UDNI)</ext-link> and the <ext-link ext-link-type="uri" xlink:href="http://www.irdirc.org/">International Rare Diseases Research Consortium (IRDiRC)</ext-link>, is beginning to facilitate interactions and information exchange among undiagnosed disease researchers worldwide. Patient advocate organizations such as <ext-link ext-link-type="uri" xlink:href="https://rarediseases.org/">National Organization for Rare Disorders (NORD)</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.eurordis.org/">European Organization for Rare Diseases (EURORDIS)</ext-link> collaborate with these consortia to facilitate diagnoses and research of rare diseases. In the absence of functional data, much of the current efforts are focused around identifying a second patient with overlapping phenotypes and genotypes to try to solve the more difficult “<italic>n</italic> = 1” cases. Considering that functional information of genes and variants will be necessary for most new disease genes and variants of unknown significance that are discovered through these efforts, we foresee that an international network of model organism researchers will boost the pace of disease gene discovery and downstream mechanistic studies necessary for understanding pathogenesis.</p>
</sec>
</sec>
<sec id="s10">
<title>The Future of Integrating Human Genomics and Model Organisms</title>
<p>The drive to assess the function of human genes based on model organism research will continue to increase. As our knowledge deepens, understanding the role of human genes will greatly benefit from this knowledge base. Several general themes are emerging that will pave the way forward.</p>
<sec id="s11">
<title>Pleiotropy and undiagnosed disease</title>
<p>Pleiotropy is the phenomenon of mutations in the same gene causing multiple phenotypes. This can be due to a gene being used in different tissues or at different stages of development, or encoding a protein that has more than one molecular function. Insights from human genome sequencing efforts provided several examples of pleiotropy. For instance, sequencing often uncovers a known disease gene in a patient with undiagnosed disease, and, in retrospect, the variant is diagnostic. However, the gene might not have been considered initially because the patient did not precisely match what was previously understood about the clinical phenotype of the disease; in retrospect, the patient’s symptoms extended beyond what were previously recognized as the core clinical features. This realization of “phenotypic expansion” is a product of limited clinical descriptions and the inherent pleiotropy of many human genes (<xref ref-type="bibr" rid="bib28">Chong <italic>et al.</italic> 2015</xref>). Phenotypic expansion often continues long after the gene is first associated with a disease. Pleiotropy in human disease can also manifest as a single gene associated with multiple distinct diseases. For example, pleiotropic effects are evident for the <italic>TRPV4</italic> locus with different mutations causing distinct diseases, as described earlier. Therefore, the key role of model organisms to facilitate understanding of the many functions of a pleiotropic gene cannot be overstated.</p>
</sec>
<sec id="s12">
<title>Noncoding variants and model organisms</title>
<p>For Mendelian disease, WES is a successful clinically available diagnostic tool. However, WES only targets coding regions, and noncoding genetic variants can also play an important role in human disease (<xref ref-type="bibr" rid="bib154">Zhang and Lupski 2015</xref>). For example, <italic>microRNA-140</italic> (<italic>miR-140</italic>) regulates palate formation in zebrafish (<xref ref-type="bibr" rid="bib40">Eberhart <italic>et al.</italic> 2008</xref>), and a single nucleotide polymorphism (SNP, rs7205289) within the human <italic>miR-140</italic> gene, which decreases miR-140 processing, was found to be strongly associated with nonsyndromic cleft palate in human patients (<xref ref-type="bibr" rid="bib86">Li <italic>et al.</italic> 2010</xref>). While some annotated noncoding but transcribed elements, such as miRNAs and long noncoding RNAs (lncRNAs) could be added to the target for sequencing, the identification of causative sequence variants in regulatory DNAs is difficult due to our incomplete understanding of the logic of human gene regulatory networks. Furthermore as additional WGS data become available, more noncoding variants will be identified. Understanding the consequences of these variants will continue to be a very significant challenge. Although there are examples of pathogenic noncoding copy number variants (CNVs) upstream of disease loci (<xref ref-type="bibr" rid="bib94">McCarroll <italic>et al.</italic> 2008</xref>; <xref ref-type="bibr" rid="bib155">Zhang <italic>et al.</italic> 2010</xref>), the current view is that the vast majority of disease-causing mutations from rare Mendelian disorders relate to coding or splicing variants. Interestingly, most GWAS (Genome Wide Association Studies) loci associated with common disorders are genetic variants in noncoding or regulatory regions (<xref ref-type="bibr" rid="bib41">Edwards <italic>et al.</italic> 2013</xref>). Given the overall lack of conservation between noncoding regions in humans and model organisms, it is challenging to study noncoding variants, although some strategies are emerging in vertebrate model organisms (<xref ref-type="bibr" rid="bib154">Zhang and Lupski 2015</xref>). In cases where the noncoding region is not conserved, model organism strategies to understand the consequences of changes in gene expression may offer the best insights. For example, if the variant can be shown to affect gene regulation in human cells or tissues (<italic>e.g.</italic>, gene expression data from RNA-seq in patient samples), then gene knockdown or overexpression in model organisms may be productive (<xref ref-type="bibr" rid="bib143">Wangler <italic>et al.</italic> 2017</xref>). However, as the field elucidates more noncoding variants associated with diseases, then more direct ways to study these regulatory variants may be needed.</p>
</sec>
<sec id="s13">
<title>Human database integration and matchmaking</title>
<p>Genetic diagnoses have greatly benefitted from information in numerous human databases. Efforts to use human genomics for diagnosis depend on comparing candidate variants to other variants at the locus found in other databases. The success of efforts, such as <ext-link ext-link-type="uri" xlink:href="https://www.ddduk.org/">Deciphering-Developmental-Disorders-Study</ext-link> (2015), <ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/">ExAC</ext-link> and its expansion project <ext-link ext-link-type="uri" xlink:href="http://gnomad.broadinstitute.org/">gnomAD (Genome Aggregation Database)</ext-link> (<xref ref-type="bibr" rid="bib82">Lek <italic>et al.</italic> 2016</xref>), <ext-link ext-link-type="uri" xlink:href="http://geno2mp.gs.washington.edu/Geno2MP/">Geno2MP</ext-link> (<xref ref-type="bibr" rid="bib29">Chong <italic>et al.</italic> 2016a</xref>), and <ext-link ext-link-type="uri" xlink:href="http://www.discovehrshare.com/">the DiscovEHR Collaboration</ext-link> (<xref ref-type="bibr" rid="bib1">Abul-Husn <italic>et al.</italic> 2016</xref>; <xref ref-type="bibr" rid="bib39">Dewey <italic>et al.</italic> 2016</xref>), in creating publically available datasets is a result of these diagnostic needs. Use of integrated match-making programs that comprise the <ext-link ext-link-type="uri" xlink:href="http://www.matchmakerexchange.org/">Matchmaker Exchange (MME)</ext-link> (<xref ref-type="bibr" rid="bib108">Philippakis <italic>et al.</italic> 2015</xref>) allows the identification of patients with similar phenotypes and genotypes across different platforms. In Matchmaker Exchange, databases such as <ext-link ext-link-type="uri" xlink:href="https://genematcher.org/">GeneMatcher</ext-link> (<xref ref-type="bibr" rid="bib128">Sobreira <italic>et al.</italic> 2015b</xref>), <ext-link ext-link-type="uri" xlink:href="https://phenomecentral.org/">PhenomeCentral</ext-link> (<xref ref-type="bibr" rid="bib23">Buske <italic>et al.</italic> 2015</xref>), <ext-link ext-link-type="uri" xlink:href="https://decipher.sanger.ac.uk/">DECIPHER (DatabasE of genomiC varIation and Phenotype in Humans using Ensembl Resources)</ext-link> (<xref ref-type="bibr" rid="bib27">Chatzimichali <italic>et al.</italic> 2015</xref>), <ext-link ext-link-type="uri" xlink:href="https://mygene2.org/MyGene2/">MyGene2</ext-link> (<xref ref-type="bibr" rid="bib30">Chong <italic>et al.</italic> 2016b</xref>), <ext-link ext-link-type="uri" xlink:href="https://seqr.broadinstitute.org/"><italic>matchbox/seqr</italic></ext-link>, and <ext-link ext-link-type="uri" xlink:href="https://mme.australiangenomics.org.au/">Australian Genomics Health Alliance (AGHA) Patient Archive</ext-link> are connected to one another, thereby supporting queries of data from &gt;20,000 unrelated patients, and facilitating prioritization of genes and variants.</p>
</sec>
<sec id="s14">
<title>Model organism resources and infrastructure</title>
<p>Maintaining and expanding the resources and infrastructure to support model organism research will be essential for the future of both undiagnosed and diagnosed disease research, for our ability to identify molecular mechanisms quickly and efficiently, and to develop potential therapies for human disease (<xref ref-type="table" rid="t3">Table 3</xref>). We strongly feel this should be embraced and well supported by the NIH and government agencies in other countries that fund biomedical research. Indeed, rapid analyses of variants of unknown significance and deeper mechanistic studies often depend upon the availability of reagents in model organisms. If these resources are not available and need to be developed, researchers will be less likely to embark on such studies. Similarly, the organism-specific databases, including <ext-link ext-link-type="uri" xlink:href="http://www.yeastgenome.org/"><italic>Saccharomyces</italic> Genome Database (SGD, budding yeast)</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://www.pombase.org/">Pombase (fission yeast)</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.wormbase.org/">WormBase (<italic>C. elegans</italic>)</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://flybase.org/">FlyBase (<italic>Drosophila</italic>)</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://zfin.org/">The Zebrafish Information Network (ZFIN, zebrafish)</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.informatics.jax.org/">Mouse Genome Informatics (MGI, mouse)</ext-link>, and <ext-link ext-link-type="uri" xlink:href="http://rgd.mcw.edu/">Rat Genome Database (RGD, rat)</ext-link>, are critical to mine, organize, and curate biological information required to prioritize candidate disease genes. Although databases and mining tools integrating information from multiple key model organism databases and corresponding human genes are being developed by the <ext-link ext-link-type="uri" xlink:href="http://www.alliancegenome.org/">Alliance of Genome Resources</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://monarchinitiative.org/">the Monarch Initiative</ext-link>, and other efforts such as <ext-link ext-link-type="uri" xlink:href="http://marrvel.org/">MARRVEL</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.gene2function.org/">Gene2Function</ext-link>, specific model organism databases will continue to play a critical role because they curate and annotate organism-specific datasets that are seminal to their respective research communities. For example, <ext-link ext-link-type="uri" xlink:href="http://flybase.org/">FlyBase</ext-link> (<xref ref-type="bibr" rid="bib17">Bilder and Irvine 2017</xref>) and <ext-link ext-link-type="uri" xlink:href="http://zfin.org/">ZFIN</ext-link> (<xref ref-type="bibr" rid="bib67">Howe <italic>et al.</italic> 2017</xref>) are queried tens of millions of times a year, mostly by members of the fly and zebrafish communities, respectively, which are estimated to consist of &gt;6000 researchers each. Hence, both an integrated databases and model organism-specific databases are required to facilitate the synergy between the medical genetics and model organism research communities.</p>
<table-wrap id="t3" position="float">
<label>Table 3</label>
<caption>
<title>Online resources cited</title>
</caption>
<table frame="hsides" rules="groups">
<col span="1" width="51.17%"/>
<col span="1" width="48.83%"/>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top">Comments from the NIH Leadership on Model Organism Research Support</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> Francis Collins at TAGC 2016 on YouTube</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://www.youtube.com/watch?v=f9FXNU1YWQo">https://www.youtube.com/watch?v=f9FXNU1YWQo</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> NIH Extramural Nexus | Open Mike | A Look at Trends in NIH’s Model Organism Research Support.</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://nexus.od.nih.gov/all/2016/07/14/a-look-at-trends-in-nihs-model-organism-research-support/">https://nexus.od.nih.gov/all/2016/07/14/a-look-at-trends-in-nihs-model-organism-research-support/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="1" scope="col" valign="top">Rare and undiagnosed disease research consortia and organizations</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> CMG-The Centers for Mendelian Genomics</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://mendelian.org/">http://mendelian.org/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> DDDS-Deciphering Developmental Disorders Study</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://www.ddduk.org/">https://www.ddduk.org/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> DiscovEHR collaboration</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://www.discovehrshare.com/">http://www.discovehrshare.com/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> EURORDIS-The European Organization for Rare Diseases</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://www.eurordis.org/">http://www.eurordis.org/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> IGNITE project</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://igniteproject.ca/">http://igniteproject.ca/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> IRDiRC-The International Rare Diseases Research Consortium</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://www.irdirc.org/">http://www.irdirc.org/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> IRUD-The Initiative on Rare and Undiagnosed Diseases</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://www.amed.go.jp/en/program/IRUD/">http://www.amed.go.jp/en/program/IRUD/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> NORD-National Organization for Rare Disorders</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://rarediseases.org/">https://rarediseases.org/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> RDMM-The Rare Diseases: Models and Mechanisms Network</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://www.rare-diseases-catalyst-network.ca/">http://www.rare-diseases-catalyst-network.ca/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> Telethon Undiagnosed Diseases Program</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://www.telethon.it/node/49281">http://www.telethon.it/node/49281</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> UDN-The Undiagnosed Diseases Network</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://undiagnosed.hms.harvard.edu/">https://undiagnosed.hms.harvard.edu/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> UDN | MOSC-Model Organisms Screening Center</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://undiagnosed.hms.harvard.edu/research/model-organisms/">https://undiagnosed.hms.harvard.edu/research/model-organisms/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> UDNI-Undiagnosed Diseases Network International</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://www.udninternational.org/">http://www.udninternational.org/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="1" scope="col" valign="top">Human genomic databases, tools and resources</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> Australian Genomics Health Alliance Patient Archive</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://mme.australiangenomics.org.au/">https://mme.australiangenomics.org.au/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> <ext-link ext-link-type="uri" xlink:href="https://ClinicalTrials.gov">ClinicalTrials.gov</ext-link>|Leflunomide+Vemurafenib in V600 Mutant Met. Melanoma</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/study/NCT01611675">https://clinicaltrials.gov/ct2/show/study/NCT01611675</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> DECIPHER-DatabasE of genomiC varIation and Phenotype in Humans using Ensembl Resources</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://decipher.sanger.ac.uk/">https://decipher.sanger.ac.uk/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> ExAC (Exome Aggregation Consortium) browser</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/">http://exac.broadinstitute.org/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> GeneMatcher</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://genematcher.org/">https://genematcher.org/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> Geno2MP</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://geno2mp.gs.washington.edu/Geno2MP/">http://geno2mp.gs.washington.edu/Geno2MP/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> gnomAD-Genome Aggregation Database</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://gnomad.broadinstitute.org/">http://gnomad.broadinstitute.org/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"><italic> matchbox/seqr</italic> at Broad Institute</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://seqr.broadinstitute.org/">https://seqr.broadinstitute.org/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> Matchmaker Exchange</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://www.matchmakerexchange.org/">http://www.matchmakerexchange.org/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> MyGene2</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://mygene2.org/MyGene2/">https://mygene2.org/MyGene2/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> OMIM-Online Mendelian Inheritance in Man</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://www.omim.org/">https://www.omim.org/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> PhenomeCentral</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://phenomecentral.org/">https://phenomecentral.org/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="1" scope="col" valign="top">Cross-species mining tools and resources</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> Alliance of Genome Resources</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://www.alliancegenome.org/">http://www.alliancegenome.org/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> DIOPT-DRSC Integrative Ortholog Prediction Tool</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://www.flyrnai.org/diopt">http://www.flyrnai.org/diopt</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> Gene2Function</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://www.gene2function.org/">http://www.gene2function.org/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> MARRVEL-Model organism Aggregated Resources for Rare Variant ExpLoration</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://marrvel.org/">http://marrvel.org/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> Monarch Initiative</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://monarchinitiative.org/">https://monarchinitiative.org/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="1" scope="col" valign="top">Model organism databases, tools and resources</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> BDSC-Bloomington Drosophila Stock Center</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://fly.bio.indiana.edu/">http://fly.bio.indiana.edu/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> BDSC | Human proteins under the control of UAS</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://fly.bio.indiana.edu/Browse/uas/uas_hsap.php">http://fly.bio.indiana.edu/Browse/uas/uas_hsap.php</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> CGC-Caenorhabditis Genetics Center</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://cgc.umn.edu/">https://cgc.umn.edu/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> FlyBase</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://flybase.org/">http://flybase.org/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> MGC-Mammalian Gene Collection</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://genecollections.nci.nih.gov/MGC/">https://genecollections.nci.nih.gov/MGC/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> MGI-Mouse Genome Informatics</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://www.informatics.jax.org/">http://www.informatics.jax.org/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> MMR-Mouse Mutant Resource</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://www.jax.org/research-and-faculty/tools/mouse-mutant-resource">https://www.jax.org/research-and-faculty/tools/mouse-mutant-resource</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> MMRRC-Mutant Mouse Resource and Research Centers</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://www.mmrrc.org/">https://www.mmrrc.org/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> Pombase</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://www.pombase.org/">https://www.pombase.org/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> RGD-Rat Genome Database</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://rgd.mcw.edu/">http://rgd.mcw.edu/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> SGD-Saccharomyces Genome Database</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://www.yeastgenome.org/">http://www.yeastgenome.org/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> WormBase</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://www.wormbase.org/">http://www.wormbase.org/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> ZFIN-The Zebrafish Information Network</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://zfin.org/">http://zfin.org/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" scope="row" valign="top"> ZIRC-Zebrafish International Resource Center</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://zebrafish.org/">https://zebrafish.org/</ext-link>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>In addition to these digital resources, the UDN, RDMM and similar projects in other countries will rely on publically distributed reagents and strains to facilitate gene and variant annotation. For example, a public collection of human cDNA libraries being assembled by the <ext-link ext-link-type="uri" xlink:href="https://genecollections.nci.nih.gov/MGC/">Mammalian Gene Collection (MGC) consortium</ext-link> (<xref ref-type="bibr" rid="bib133">Temple <italic>et al.</italic> 2009</xref>). Transgenic yeast (<xref ref-type="bibr" rid="bib72">Kachroo <italic>et al.</italic> 2015</xref>), <ext-link ext-link-type="uri" xlink:href="http://fly.bio.indiana.edu/Browse/uas/uas_hsap.php"><italic>Drosophila</italic></ext-link>, and zebrafish (<xref ref-type="bibr" rid="bib35">Davis <italic>et al.</italic> 2014</xref>) strains that allow expression of these human cDNAs <italic>in vivo</italic> in model organisms will provide easily accessible and valuable “off-the-shelf” resources to support and encourage the use of model organisms for functional analyses of human variants. In addition, a collection of gene knock-in (<xref ref-type="bibr" rid="bib100">Nagarkar-Jaiswal <italic>et al.</italic> 2015</xref>) or BAC/phosmid transgenic lines (<xref ref-type="bibr" rid="bib116">Sarov <italic>et al.</italic> 2016</xref>) that tag most proteins in the genome with epitopes or fluorescent proteins would allow investigators to assess expression, subcellular distribution, and function of genes quickly by integrating cell biological, biochemical, and proteomic approaches. For example, GFP-tagged strains can also be used to conditionally knockdown the transcript or protein of interest in a reversible and temporally and spatially controlled manner (<xref ref-type="bibr" rid="bib100">Nagarkar-Jaiswal <italic>et al.</italic> 2015</xref>). Stock centers, including the <ext-link ext-link-type="uri" xlink:href="http://fly.bio.indiana.edu/">Bloomington <italic>Drosophila</italic> Stock Center (BDSC)</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://cgc.umn.edu/"><italic>Caenorhabditis</italic> Genetics Center (CGC)</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://zebrafish.org/">Zebrafish International Resource Center (ZIRC)</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://www.mmrrc.org/">Mutant Mouse Resource and Research Centers (MMRRC)</ext-link>, and <ext-link ext-link-type="uri" xlink:href="https://www.jax.org/research-and-faculty/tools/mouse-mutant-resource">Mouse Mutant Resource (MMR)</ext-link> that assist in the maintenance of these and other useful mutant and transgenic resources depend upon continued support by the NIH, international research community, and end-users. By combining these resources, and the genotype to phenotype information obtained from human patients, one can more rapidly study the LOF phenotype, test whether the molecular function of the human and model organism genes are conserved, determine whether a variant of unknown significance is functional, study the expression pattern and subcellular localization of the protein of interest, identify physical interaction partners, and understand the function of the gene in the organ system and cell type of interest (<xref ref-type="bibr" rid="bib15">Bellen and Yamamoto 2015</xref>). Maintaining and expanding the resources of model organism communities will provide invaluable information to expand our ability to diagnose and dissect the molecular mechanisms underlying human diseases.</p>
<p>Finally, nonmodel organisms may also provide key insights into disease pathogenesis (<xref ref-type="bibr" rid="bib115">Russell <italic>et al.</italic> 2017</xref>). Indeed, some animals adapted to a specific environment show a phenotype that would be lethal or detrimental in humans. These include osteopenia and profound anemia in Antarctic icefish or eye loss and metabolic syndromes in cavefish (<xref ref-type="bibr" rid="bib4">Albertson <italic>et al.</italic> 2009</xref>). These organisms can be considered as “evolutionary mutant models,” which may help us better understand similar disease conditions in human. These organisms may also provide critical clues about key molecular mechanisms that could be targeted for therapeutic interventions.</p>
</sec>
<sec id="s15">
<title>Collaboration and teamwork</title>
<p>Teamwork is paramount to drive model organism research in undiagnosed disease. Collaboration between clinicians who identify potential genes of interest and biologists who study model organisms to assess the function of homologous genes forms a first layer. In the CMG model, the clinicians and researchers seek collaboration based on the large number of candidate variants identified. Collaborative efforts are established with model organism researchers on a case-by-case basis. Although this strategy has been very productive, it may be difficult to expand outside large genomic centers. This justifies the need for approaches like the RDMM and UDN. In the UDN model, novel human variants are provided to a central entity, the MOSC, which is responsible for rapid assessment of the variants. The advantages are that the MOSC follows a standard approach in defined model organisms so that each variant is subject to the same analytical process. This tactic allows coordinated and systematic processing of numerous variants simultaneously. However, this process may not take full advantage of the rich expertise of investigators in particular areas. In the RDMM model variants are distributed, and the advantage of this organization is that novel variants are studied by experts with strong interest in a particular gene, tissue, or pathway. However, the methods and mechanistic depth for each variant may differ significantly because a centralized organization allows for a more efficient workflow and better resource allocation.</p>
<p>It is possible that a model combining the centralized (UDN-MOSC) approach and the distributive (RDMM) approach may ultimately be the best way to study candidate variants in model organisms. A potential workflow would be first to engage a primary center where genome biologists check variants against other human genomic datasets, chose the ideal model organism, select the best technologies, efficiently and economically generate the reagents, and rapidly test candidate variants. The acquired information and reagents could then be distributed to expert colleagues who wish to pursue the biology of the gene and disease in depth. Structuring multi-organism teams in the face of rapidly expanding lists of candidate variants and genes is a challenge that requires clinicians, human geneticists, bioinformaticians, and model organism investigators to work together. This collaboration allows rapid translation of knowledge obtained in one species to another and avoids duplication of effort. Integrating and acknowledging the strengths of each model organism is required to accelerate discoveries that identify pathogenic mechanisms and lead to development of novel therapeutic strategies.</p>
</sec>
</sec>
<sec id="s16" sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SM1">
<media xlink:href="9FileS1.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We thank James R. Lupski, Paolo Moretti, Loren Del Mar Pena, Joy D. Cogan, and Jasper Rine for valuable input and critical reading of the manuscript. This work was supported in part by National Institutes of Health (NIH) grants U54NS093793 (H.J.B., M.F.W., S.Y., M.W., and J.P.), R24OD022005 (H.J.B.), R01GM067858 (H.J.B.), HD22486 (M.W.) GM114438 (M.W.), Alzheimer’s Association (NIRH-15-364099 to S.Y.), and Simons Foundation Autism Research Initiative (368479 to M.F.W. and S.Y.). H.J.B. is an investigator of the Howard Hughes Medical Institute (HHMI) and received support from the Robert A. and Renee E. Belfer Family Foundation, the Huffington Foundation, and Target ALS. H.-T.C. is supported by an American Academy of Neurology (AAN) Neuroscience Research Scholarship and the CNCDP-K12 Fellowship from the National Institute of Neurological Disorders and Stroke (1K12NS098482). J.E.P. was supported by the Ting Tsung and Wei Fong Chao Foundation and National Human Genome Research Institute (NHGRI) grant K08 HG008986. The Rare Diseases Models and Mechanisms (RDMM) Network is funded by the Canadian Institutes of Health Research grant RCN-137793. P.M.C. is funded in part by clinician scientist awards from the Canadian Institutes of Health Research (CIHR) (RN-315908) and the FRQS (30647).</p>
</ack>
<fn-group>
<fn id="fn2">
<label>2</label>
<p>A full list of members is provided as Supplementary Material.</p>
</fn>
<fn id="fn1">
<p>Communicating editor: M. Johnston</p>
</fn>
</fn-group>
<ref-list>
<title>Literature Cited</title>
<ref id="bib1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abul-Husn</surname><given-names>N. S.</given-names></name><name><surname>Manickam</surname><given-names>K.</given-names></name><name><surname>Jones</surname><given-names>L. K.</given-names></name><name><surname>Wright</surname><given-names>E. A.</given-names></name><name><surname>Hartzel</surname><given-names>D. N.</given-names></name><etal></etal></person-group>, <year>2016</year> <article-title>Genetic identification of familial hypercholesterolemia within a single U.S. health care system.</article-title>
<source/>Science
<volume>354</volume>: <fpage>aaf7000</fpage>.<pub-id pub-id-type="pmid">28008010</pub-id></mixed-citation>
</ref>
<ref id="bib2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afzal</surname><given-names>A. R.</given-names></name><name><surname>Rajab</surname><given-names>A.</given-names></name><name><surname>Fenske</surname><given-names>C. D.</given-names></name><name><surname>Oldridge</surname><given-names>M.</given-names></name><name><surname>Elanko</surname><given-names>N.</given-names></name><etal></etal></person-group>, <year>2000</year> <article-title>Recessive Robinow syndrome, allelic to dominant brachydactyly type B, is caused by mutation of ROR2.</article-title>
<source/>Nat. Genet.
<volume>25</volume>: <fpage>419</fpage>–<lpage>422</lpage>.<pub-id pub-id-type="pmid">10932186</pub-id></mixed-citation>
</ref>
<ref id="bib3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albert</surname><given-names>T. J.</given-names></name><name><surname>Molla</surname><given-names>M. N.</given-names></name><name><surname>Muzny</surname><given-names>D. M.</given-names></name><name><surname>Nazareth</surname><given-names>L.</given-names></name><name><surname>Wheeler</surname><given-names>D.</given-names></name><etal></etal></person-group>, <year>2007</year> <article-title>Direct selection of human genomic loci by microarray hybridization.</article-title>
<source/>Nat. Methods
<volume>4</volume>: <fpage>903</fpage>–<lpage>905</lpage>.<pub-id pub-id-type="pmid">17934467</pub-id></mixed-citation>
</ref>
<ref id="bib4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albertson</surname><given-names>R. C.</given-names></name><name><surname>Cresko</surname><given-names>W.</given-names></name><name><surname>Detrich</surname><given-names>H. W.</given-names><suffix>III</suffix></name><name><surname>Postlethwait</surname><given-names>J. H.</given-names></name></person-group>, <year>2009</year> <article-title>Evolutionary mutant models for human disease.</article-title>
<source/>Trends Genet.
<volume>25</volume>: <fpage>74</fpage>–<lpage>81</lpage>.<pub-id pub-id-type="pmid">19108930</pub-id></mixed-citation>
</ref>
<ref id="bib5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoyagi</surname><given-names>K.</given-names></name><name><surname>Rossignol</surname><given-names>E.</given-names></name><name><surname>Hamdan</surname><given-names>F. F.</given-names></name><name><surname>Mulcahy</surname><given-names>B.</given-names></name><name><surname>Xie</surname><given-names>L.</given-names></name><etal></etal></person-group>, <year>2015</year> <article-title>A gain-of-function mutation in NALCN in a child with intellectual disability, ataxia, and arthrogryposis.</article-title>
<source/>Hum. Mutat.
<volume>36</volume>: <fpage>753</fpage>–<lpage>757</lpage>.<pub-id pub-id-type="pmid">25864427</pub-id></mixed-citation>
</ref>
<ref id="bib6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashraf</surname><given-names>S.</given-names></name><name><surname>Gee</surname><given-names>H. Y.</given-names></name><name><surname>Woerner</surname><given-names>S.</given-names></name><name><surname>Xie</surname><given-names>L. X.</given-names></name><name><surname>Vega-Warner</surname><given-names>V.</given-names></name><etal></etal></person-group>, <year>2013</year> <article-title>ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption.</article-title>
<source/>J. Clin. Invest.
<volume>123</volume>: <fpage>5179</fpage>–<lpage>5189</lpage>.<pub-id pub-id-type="pmid">24270420</pub-id></mixed-citation>
</ref>
<ref id="bib7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auer-Grumbach</surname><given-names>M.</given-names></name><name><surname>Olschewski</surname><given-names>A.</given-names></name><name><surname>Papic</surname><given-names>L.</given-names></name><name><surname>Kremer</surname><given-names>H.</given-names></name><name><surname>McEntagart</surname><given-names>M. E.</given-names></name><etal></etal></person-group>, <year>2010</year> <article-title>Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C.</article-title>
<source/>Nat. Genet.
<volume>42</volume>: <fpage>160</fpage>–<lpage>164</lpage>.<pub-id pub-id-type="pmid">20037588</pub-id></mixed-citation>
</ref>
<ref id="bib8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bainbridge</surname><given-names>M. N.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Burgess</surname><given-names>D. L.</given-names></name><name><surname>Kovar</surname><given-names>C.</given-names></name><name><surname>Rodesch</surname><given-names>M. J.</given-names></name><etal></etal></person-group>, <year>2010</year> <article-title>Whole exome capture in solution with 3 Gbp of data.</article-title>
<source/>Genome Biol.
<volume>11</volume>: <fpage>R62</fpage>.<pub-id pub-id-type="pmid">20565776</pub-id></mixed-citation>
</ref>
<ref id="bib9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balter</surname><given-names>M.</given-names></name><name><surname>Vogel</surname><given-names>G.</given-names></name></person-group>, <year>2001</year> <article-title>Nobel prize in physiology or medicine. Cycling toward Stockholm.</article-title>
<source/>Science
<volume>294</volume>: <fpage>502</fpage>–<lpage>503</lpage>.<pub-id pub-id-type="pmid">11641478</pub-id></mixed-citation>
</ref>
<ref id="bib10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bamshad</surname><given-names>M. J.</given-names></name><name><surname>Shendure</surname><given-names>J. A.</given-names></name><name><surname>Valle</surname><given-names>D.</given-names></name><name><surname>Hamosh</surname><given-names>A.</given-names></name><name><surname>Lupski</surname><given-names>J. R.</given-names></name><etal></etal></person-group>, <year>2012</year> <article-title>The Centers for Mendelian Genomics: a new large-scale initiative to identify the genes underlying rare Mendelian conditions.</article-title>
<source/>Am. J. Med. Genet. A.
<volume>158A</volume>: <fpage>1523</fpage>–<lpage>1525</lpage>.<pub-id pub-id-type="pmid">22628075</pub-id></mixed-citation>
</ref>
<ref id="bib11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bard</surname><given-names>F.</given-names></name><name><surname>Casano</surname><given-names>L.</given-names></name><name><surname>Mallabiabarrena</surname><given-names>A.</given-names></name><name><surname>Wallace</surname><given-names>E.</given-names></name><name><surname>Saito</surname><given-names>K.</given-names></name><etal></etal></person-group>, <year>2006</year> <article-title>Functional genomics reveals genes involved in protein secretion and Golgi organization.</article-title>
<source/>Nature
<volume>439</volume>: <fpage>604</fpage>–<lpage>607</lpage>.<pub-id pub-id-type="pmid">16452979</pub-id></mixed-citation>
</ref>
<ref id="bib12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bashamboo</surname><given-names>A.</given-names></name><name><surname>Donohoue</surname><given-names>P. A.</given-names></name><name><surname>Vilain</surname><given-names>E.</given-names></name><name><surname>Rojo</surname><given-names>S.</given-names></name><name><surname>Calvel</surname><given-names>P.</given-names></name><etal></etal></person-group>, <year>2016</year> <article-title>A recurrent p.Arg92Trp variant in steroidogenic factor-1 (NR5A1) can act as a molecular switch in human sex development.</article-title>
<source/>Hum. Mol. Genet.
<volume>25</volume>: <fpage>3446</fpage>–<lpage>3453</lpage>.<pub-id pub-id-type="pmid">27378692</pub-id></mixed-citation>
</ref>
<ref id="bib13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baynam</surname><given-names>G.</given-names></name><name><surname>Broley</surname><given-names>S.</given-names></name><name><surname>Bauskis</surname><given-names>A.</given-names></name><name><surname>Pachter</surname><given-names>N.</given-names></name><name><surname>McKenzie</surname><given-names>F.</given-names></name><etal></etal></person-group>, <year>2017</year> <article-title>Initiating an undiagnosed diseases program in the Western Australian public health system.</article-title>
<source/>Orphanet J. Rare Dis.
<volume>12</volume>: <fpage>83</fpage>.<pub-id pub-id-type="pmid">28468665</pub-id></mixed-citation>
</ref>
<ref id="bib14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beaulieu</surname><given-names>C. L.</given-names></name><name><surname>Majewski</surname><given-names>J.</given-names></name><name><surname>Schwartzentruber</surname><given-names>J.</given-names></name><name><surname>Samuels</surname><given-names>M. E.</given-names></name><name><surname>Fernandez</surname><given-names>B. A.</given-names></name><etal></etal></person-group>, <year>2014</year> <article-title>FORGE Canada Consortium: outcomes of a 2-year national rare-disease gene-discovery project.</article-title>
<source/>Am. J. Hum. Genet.
<volume>94</volume>: <fpage>809</fpage>–<lpage>817</lpage>.<pub-id pub-id-type="pmid">24906018</pub-id></mixed-citation>
</ref>
<ref id="bib15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellen</surname><given-names>H. J.</given-names></name><name><surname>Yamamoto</surname><given-names>S.</given-names></name></person-group>, <year>2015</year> <article-title>Morgan’s legacy: fruit flies and the functional annotation of conserved genes.</article-title>
<source/>Cell
<volume>163</volume>: <fpage>12</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="pmid">26406362</pub-id></mixed-citation>
</ref>
<ref id="bib16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellen</surname><given-names>H. J.</given-names></name><name><surname>Tong</surname><given-names>C.</given-names></name><name><surname>Tsuda</surname><given-names>H.</given-names></name></person-group>, <year>2010</year> <article-title>100 years of Drosophila research and its impact on vertebrate neuroscience: a history lesson for the future.</article-title>
<source/>Nat. Rev. Neurosci.
<volume>11</volume>: <fpage>514</fpage>–<lpage>522</lpage>.<pub-id pub-id-type="pmid">20383202</pub-id></mixed-citation>
</ref>
<ref id="bib17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilder</surname><given-names>D.</given-names></name><name><surname>Irvine</surname><given-names>K. D.</given-names></name></person-group>, <year>2017</year> <article-title>Taking stock of the Drosophila research ecosystem.</article-title>
<source/>Genetics
<volume>206</volume>: <fpage>1227</fpage>–<lpage>1236</lpage>.<pub-id pub-id-type="pmid">28684603</pub-id></mixed-citation>
</ref>
<ref id="bib18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blair</surname><given-names>D. R.</given-names></name><name><surname>Lyttle</surname><given-names>C. S.</given-names></name><name><surname>Mortensen</surname><given-names>J. M.</given-names></name><name><surname>Bearden</surname><given-names>C. F.</given-names></name><name><surname>Jensen</surname><given-names>A. B.</given-names></name><etal></etal></person-group>, <year>2013</year> <article-title>A nondegenerate code of deleterious variants in Mendelian loci contributes to complex disease risk.</article-title>
<source/>Cell
<volume>155</volume>: <fpage>70</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">24074861</pub-id></mixed-citation>
</ref>
<ref id="bib19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boatman</surname><given-names>S.</given-names></name><name><surname>Barrett</surname><given-names>F.</given-names></name><name><surname>Satishchandran</surname><given-names>S.</given-names></name><name><surname>Jing</surname><given-names>L.</given-names></name><name><surname>Shestopalov</surname><given-names>I.</given-names></name><etal></etal></person-group>, <year>2013</year> <article-title>Assaying hematopoiesis using zebrafish.</article-title>
<source/>Blood Cells Mol. Dis.
<volume>51</volume>: <fpage>271</fpage>–<lpage>276</lpage>.<pub-id pub-id-type="pmid">23916372</pub-id></mixed-citation>
</ref>
<ref id="bib20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonini</surname><given-names>N. M.</given-names></name><name><surname>Berger</surname><given-names>S. L.</given-names></name></person-group>, <year>2017</year> <article-title>The sustained impact of model organisms-in genetics and epigenetics.</article-title>
<source/>Genetics
<volume>205</volume>: <fpage>1</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">28049700</pub-id></mixed-citation>
</ref>
<ref id="bib21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braasch</surname><given-names>I.</given-names></name><name><surname>Gehrke</surname><given-names>A. R.</given-names></name><name><surname>Smith</surname><given-names>J. J.</given-names></name><name><surname>Kawasaki</surname><given-names>K.</given-names></name><name><surname>Manousaki</surname><given-names>T.</given-names></name><etal></etal></person-group>, <year>2016</year> <article-title>The spotted gar genome illuminates vertebrate evolution and facilitates human-teleost comparisons.</article-title>
<source/>Nat. Genet.
<volume>48</volume>: <fpage>427</fpage>–<lpage>437</lpage>.<pub-id pub-id-type="pmid">26950095</pub-id></mixed-citation>
</ref>
<ref id="bib22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bunn</surname><given-names>K. J.</given-names></name><name><surname>Daniel</surname><given-names>P.</given-names></name><name><surname>Rosken</surname><given-names>H. S.</given-names></name><name><surname>O’Neill</surname><given-names>A. C.</given-names></name><name><surname>Cameron-Christie</surname><given-names>S. R.</given-names></name><etal></etal></person-group>, <year>2015</year> <article-title>Mutations in DVL1 cause an osteosclerotic form of Robinow syndrome.</article-title>
<source/>Am. J. Hum. Genet.
<volume>96</volume>: <fpage>623</fpage>–<lpage>630</lpage>.<pub-id pub-id-type="pmid">25817014</pub-id></mixed-citation>
</ref>
<ref id="bib23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buske</surname><given-names>O. J.</given-names></name><name><surname>Girdea</surname><given-names>M.</given-names></name><name><surname>Dumitriu</surname><given-names>S.</given-names></name><name><surname>Gallinger</surname><given-names>B.</given-names></name><name><surname>Hartley</surname><given-names>T.</given-names></name><etal></etal></person-group>, <year>2015</year> <article-title>PhenomeCentral: a portal for phenotypic and genotypic matchmaking of patients with rare genetic diseases.</article-title>
<source/>Hum. Mutat.
<volume>36</volume>: <fpage>931</fpage>–<lpage>940</lpage>.<pub-id pub-id-type="pmid">26251998</pub-id></mixed-citation>
</ref>
<ref id="bib24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceol</surname><given-names>C. J.</given-names></name><name><surname>Houvras</surname><given-names>Y.</given-names></name><name><surname>Jane-Valbuena</surname><given-names>J.</given-names></name><name><surname>Bilodeau</surname><given-names>S.</given-names></name><name><surname>Orlando</surname><given-names>D. A.</given-names></name><etal></etal></person-group>, <year>2011</year> <article-title>The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset.</article-title>
<source/>Nature
<volume>471</volume>: <fpage>513</fpage>–<lpage>517</lpage>.<pub-id pub-id-type="pmid">21430779</pub-id></mixed-citation>
</ref>
<ref id="bib25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>H. T.</given-names></name><name><surname>Davids</surname><given-names>M.</given-names></name><name><surname>Burke</surname><given-names>E.</given-names></name><name><surname>Pappas</surname><given-names>J. G.</given-names></name><name><surname>Rosenfeld</surname><given-names>J. A.</given-names></name><etal></etal></person-group>, <year>2017</year><comment>a</comment> <article-title>A syndromic neurodevelopmental disorder caused by de novo variants in EBF3.</article-title>
<source/>Am. J. Hum. Genet.
<volume>100</volume>: <fpage>128</fpage>–<lpage>137</lpage>.<pub-id pub-id-type="pmid">28017372</pub-id></mixed-citation>
</ref>
<ref id="bib26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>H. T.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Bellen</surname><given-names>H. J.</given-names></name></person-group>, <year>2017</year><comment>b</comment> <article-title>Building dialogues between clinical and biomedical research through cross-species collaborations.</article-title>
<source/>Semin. Cell Dev. Biol. pii: S1084–9521(17)30260-4.</mixed-citation>
</ref>
<ref id="bib27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chatzimichali</surname><given-names>E. A.</given-names></name><name><surname>Brent</surname><given-names>S.</given-names></name><name><surname>Hutton</surname><given-names>B.</given-names></name><name><surname>Perrett</surname><given-names>D.</given-names></name><name><surname>Wright</surname><given-names>C. F.</given-names></name><etal></etal></person-group>, <year>2015</year> <article-title>Facilitating collaboration in rare genetic disorders through effective matchmaking in DECIPHER.</article-title>
<source/>Hum. Mutat.
<volume>36</volume>: <fpage>941</fpage>–<lpage>949</lpage>.<pub-id pub-id-type="pmid">26220709</pub-id></mixed-citation>
</ref>
<ref id="bib28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chong</surname><given-names>J. X.</given-names></name><name><surname>Buckingham</surname><given-names>K. J.</given-names></name><name><surname>Jhangiani</surname><given-names>S. N.</given-names></name><name><surname>Boehm</surname><given-names>C.</given-names></name><name><surname>Sobreira</surname><given-names>N.</given-names></name><etal></etal></person-group>, <year>2015</year> <article-title>The genetic basis of Mendelian phenotypes: discoveries, challenges, and opportunities.</article-title>
<source/>Am. J. Hum. Genet.
<volume>97</volume>: <fpage>199</fpage>–<lpage>215</lpage>.<pub-id pub-id-type="pmid">26166479</pub-id></mixed-citation>
</ref>
<ref id="bib29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chong</surname><given-names>J. X.</given-names></name><name><surname>Caputo</surname><given-names>V.</given-names></name><name><surname>Phelps</surname><given-names>I. G.</given-names></name><name><surname>Stella</surname><given-names>L.</given-names></name><name><surname>Worgan</surname><given-names>L.</given-names></name><etal></etal></person-group>, <year>2016</year><comment>a</comment> <article-title>Recessive inactivating mutations in TBCK, encoding a Rab GTPase-activating protein, cause severe infantile syndromic encephalopathy.</article-title>
<source/>Am. J. Hum. Genet.
<volume>98</volume>: <fpage>772</fpage>–<lpage>781</lpage>.<pub-id pub-id-type="pmid">27040692</pub-id></mixed-citation>
</ref>
<ref id="bib30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chong</surname><given-names>J. X.</given-names></name><name><surname>Yu</surname><given-names>J. H.</given-names></name><name><surname>Lorentzen</surname><given-names>P.</given-names></name><name><surname>Park</surname><given-names>K. M.</given-names></name><name><surname>Jamal</surname><given-names>S. M.</given-names></name><etal></etal></person-group>, <year>2016</year><comment>b</comment> <article-title>Gene discovery for Mendelian conditions via social networking: de novo variants in KDM1A cause developmental delay and distinctive facial features.</article-title>
<source/>Genet. Med.
<volume>18</volume>: <fpage>788</fpage>–<lpage>795</lpage>.<pub-id pub-id-type="pmid">26656649</pub-id></mixed-citation>
</ref>
<ref id="bib31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciani</surname><given-names>L.</given-names></name><name><surname>Patel</surname><given-names>A.</given-names></name><name><surname>Allen</surname><given-names>N. D.</given-names></name><name><surname>ffrench-Constant</surname><given-names>C.</given-names></name></person-group>, <year>2003</year> <article-title>Mice lacking the giant protocadherin mFAT1 exhibit renal slit junction abnormalities and a partially penetrant cyclopia and anophthalmia phenotype.</article-title>
<source/>Mol. Cell. Biol.
<volume>23</volume>: <fpage>3575</fpage>–<lpage>3582</lpage>.<pub-id pub-id-type="pmid">12724416</pub-id></mixed-citation>
</ref>
<ref id="bib32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cosens</surname><given-names>D. J.</given-names></name><name><surname>Manning</surname><given-names>A.</given-names></name></person-group>, <year>1969</year> <article-title>Abnormal electroretinogram from a Drosophila mutant.</article-title>
<source/>Nature
<volume>224</volume>: <fpage>285</fpage>–<lpage>287</lpage>.<pub-id pub-id-type="pmid">5344615</pub-id></mixed-citation>
</ref>
<ref id="bib33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coventry</surname><given-names>A.</given-names></name><name><surname>Bull-Otterson</surname><given-names>L. M.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Clark</surname><given-names>A. G.</given-names></name><name><surname>Maxwell</surname><given-names>T. J.</given-names></name><etal></etal></person-group>, <year>2010</year> <article-title>Deep resequencing reveals excess rare recent variants consistent with explosive population growth.</article-title>
<source/>Nat. Commun.
<volume>1</volume>: <fpage>131</fpage>.<pub-id pub-id-type="pmid">21119644</pub-id></mixed-citation>
</ref>
<ref id="bib34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>J.</given-names></name><name><surname>Cho</surname><given-names>T. J.</given-names></name><name><surname>Unger</surname><given-names>S.</given-names></name><name><surname>Lausch</surname><given-names>E.</given-names></name><name><surname>Nishimura</surname><given-names>G.</given-names></name><etal></etal></person-group>, <year>2010</year> <article-title>TRPV4-pathy, a novel channelopathy affecting diverse systems.</article-title>
<source/>J. Hum. Genet.
<volume>55</volume>: <fpage>400</fpage>–<lpage>402</lpage>.<pub-id pub-id-type="pmid">20505684</pub-id></mixed-citation>
</ref>
<ref id="bib35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>E. E.</given-names></name><name><surname>Frangakis</surname><given-names>S.</given-names></name><name><surname>Katsanis</surname><given-names>N.</given-names></name></person-group>, <year>2014</year> <article-title>Interpreting human genetic variation with in vivo zebrafish assays.</article-title>
<source/>Biochim. Biophys. Acta
<volume>1842</volume>: <fpage>1960</fpage>–<lpage>1970</lpage>.<pub-id pub-id-type="pmid">24887202</pub-id></mixed-citation>
</ref>
<ref id="bib36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Deciphering-Developmental-Disorders-Study</collab></person-group>, <year>2015</year> <article-title>Large-scale discovery of novel genetic causes of developmental disorders.</article-title>
<source/>Nature
<volume>519</volume>: <fpage>223</fpage>–<lpage>228</lpage>.<pub-id pub-id-type="pmid">25533962</pub-id></mixed-citation>
</ref>
<ref id="bib37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dehal</surname><given-names>P.</given-names></name><name><surname>Boore</surname><given-names>J. L.</given-names></name></person-group>, <year>2005</year> <article-title>Two rounds of whole genome duplication in the ancestral vertebrate.</article-title>
<source/>PLoS Biol.
<volume>3</volume>: <fpage>e314</fpage>.<pub-id pub-id-type="pmid">16128622</pub-id></mixed-citation>
</ref>
<ref id="bib38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>H. X.</given-names></name><name><surname>Klein</surname><given-names>C. J.</given-names></name><name><surname>Yan</surname><given-names>J.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><etal></etal></person-group>, <year>2010</year> <article-title>Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4.</article-title>
<source/>Nat. Genet.
<volume>42</volume>: <fpage>165</fpage>–<lpage>169</lpage>.<pub-id pub-id-type="pmid">20037587</pub-id></mixed-citation>
</ref>
<ref id="bib39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dewey</surname><given-names>F. E.</given-names></name><name><surname>Murray</surname><given-names>M. F.</given-names></name><name><surname>Overton</surname><given-names>J. D.</given-names></name><name><surname>Habegger</surname><given-names>L.</given-names></name><name><surname>Leader</surname><given-names>J. B.</given-names></name><etal></etal></person-group>, <year>2016</year> <article-title>Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study.</article-title>
<source/>Science
<volume>354</volume>: <fpage>aaf6814</fpage>.<pub-id pub-id-type="pmid">28008009</pub-id></mixed-citation>
</ref>
<ref id="bib40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eberhart</surname><given-names>J. K.</given-names></name><name><surname>He</surname><given-names>X.</given-names></name><name><surname>Swartz</surname><given-names>M. E.</given-names></name><name><surname>Yan</surname><given-names>Y. L.</given-names></name><name><surname>Song</surname><given-names>H.</given-names></name><etal></etal></person-group>, <year>2008</year> <article-title>MicroRNA Mirn140 modulates Pdgf signaling during palatogenesis.</article-title>
<source/>Nat. Genet.
<volume>40</volume>: <fpage>290</fpage>–<lpage>298</lpage>.<pub-id pub-id-type="pmid">18264099</pub-id></mixed-citation>
</ref>
<ref id="bib41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>S. L.</given-names></name><name><surname>Beesley</surname><given-names>J.</given-names></name><name><surname>French</surname><given-names>J. D.</given-names></name><name><surname>Dunning</surname><given-names>A. M.</given-names></name></person-group>, <year>2013</year> <article-title>Beyond GWASs: illuminating the dark road from association to function.</article-title>
<source/>Am. J. Hum. Genet.
<volume>93</volume>: <fpage>779</fpage>–<lpage>797</lpage>.<pub-id pub-id-type="pmid">24210251</pub-id></mixed-citation>
</ref>
<ref id="bib42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eldomery</surname><given-names>M. K.</given-names></name><name><surname>Coban-Akdemir</surname><given-names>Z.</given-names></name><name><surname>Harel</surname><given-names>T.</given-names></name><name><surname>Rosenfeld</surname><given-names>J. A.</given-names></name><name><surname>Gambin</surname><given-names>T.</given-names></name><etal></etal></person-group>, <year>2017</year> <article-title>Lessons learned from additional research analyses of unsolved clinical exome cases.</article-title>
<source/>Genome Med.
<volume>9</volume>: <fpage>26</fpage>.<pub-id pub-id-type="pmid">28327206</pub-id></mixed-citation>
</ref>
<ref id="bib43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellis</surname><given-names>H. M.</given-names></name><name><surname>Horvitz</surname><given-names>H. R.</given-names></name></person-group>, <year>1986</year> <article-title>Genetic control of programmed cell death in the nematode C. elegans.</article-title>
<source/>Cell
<volume>44</volume>: <fpage>817</fpage>–<lpage>829</lpage>.<pub-id pub-id-type="pmid">3955651</pub-id></mixed-citation>
</ref>
<ref id="bib44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farwell</surname><given-names>K. D.</given-names></name><name><surname>Shahmirzadi</surname><given-names>L.</given-names></name><name><surname>El-Khechen</surname><given-names>D.</given-names></name><name><surname>Powis</surname><given-names>Z.</given-names></name><name><surname>Chao</surname><given-names>E. C.</given-names></name><etal></etal></person-group>, <year>2015</year> <article-title>Enhanced utility of family-centered diagnostic exome sequencing with inheritance model-based analysis: results from 500 unselected families with undiagnosed genetic conditions.</article-title>
<source/>Genet. Med.
<volume>17</volume>: <fpage>578</fpage>–<lpage>586</lpage>.<pub-id pub-id-type="pmid">25356970</pub-id></mixed-citation>
</ref>
<ref id="bib45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fire</surname><given-names>A.</given-names></name><name><surname>Xu</surname><given-names>S.</given-names></name><name><surname>Montgomery</surname><given-names>M. K.</given-names></name><name><surname>Kostas</surname><given-names>S. A.</given-names></name><name><surname>Driver</surname><given-names>S. E.</given-names></name><etal></etal></person-group>, <year>1998</year> <article-title>Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.</article-title>
<source/>Nature
<volume>391</volume>: <fpage>806</fpage>–<lpage>811</lpage>.<pub-id pub-id-type="pmid">9486653</pub-id></mixed-citation>
</ref>
<ref id="bib46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Force</surname><given-names>A.</given-names></name><name><surname>Lynch</surname><given-names>M.</given-names></name><name><surname>Pickett</surname><given-names>F. B.</given-names></name><name><surname>Amores</surname><given-names>A.</given-names></name><name><surname>Yan</surname><given-names>Y. L.</given-names></name><etal></etal></person-group>, <year>1999</year> <article-title>Preservation of duplicate genes by complementary, degenerative mutations.</article-title>
<source/>Genetics
<volume>151</volume>: <fpage>1531</fpage>–<lpage>1545</lpage>.<pub-id pub-id-type="pmid">10101175</pub-id></mixed-citation>
</ref>
<ref id="bib47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gahl</surname><given-names>W. A.</given-names></name><name><surname>Markello</surname><given-names>T. C.</given-names></name><name><surname>Toro</surname><given-names>C.</given-names></name><name><surname>Fajardo</surname><given-names>K. F.</given-names></name><name><surname>Sincan</surname><given-names>M.</given-names></name><etal></etal></person-group>, <year>2012</year> <article-title>The National Institutes of Health Undiagnosed Diseases Program: insights into rare diseases.</article-title>
<source/>Genet. Med.
<volume>14</volume>: <fpage>51</fpage>–<lpage>59</lpage>.<pub-id pub-id-type="pmid">22237431</pub-id></mixed-citation>
</ref>
<ref id="bib48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gahl</surname><given-names>W. A.</given-names></name><name><surname>Mulvihill</surname><given-names>J. J.</given-names></name><name><surname>Toro</surname><given-names>C.</given-names></name><name><surname>Markello</surname><given-names>T. C.</given-names></name><name><surname>Wise</surname><given-names>A. L.</given-names></name><etal></etal></person-group>, <year>2016</year> <article-title>The NIH undiagnosed diseases program and network: applications to modern medicine.</article-title>
<source/>Mol. Genet. Metab.
<volume>117</volume>: <fpage>393</fpage>–<lpage>400</lpage>.<pub-id pub-id-type="pmid">26846157</pub-id></mixed-citation>
</ref>
<ref id="bib49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gambin</surname><given-names>T.</given-names></name><name><surname>Akdemir</surname><given-names>Z. C.</given-names></name><name><surname>Yuan</surname><given-names>B.</given-names></name><name><surname>Gu</surname><given-names>S.</given-names></name><name><surname>Chiang</surname><given-names>T.</given-names></name><etal></etal></person-group>, <year>2017</year> <article-title>Homozygous and hemizygous CNV detection from exome sequencing data in a Mendelian disease cohort.</article-title>
<source/>Nucleic Acids Res.
<volume>45</volume>: <fpage>1633</fpage>–<lpage>1648</lpage>.<pub-id pub-id-type="pmid">27980096</pub-id></mixed-citation>
</ref>
<ref id="bib50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Z.</given-names></name><name><surname>Waggoner</surname><given-names>D.</given-names></name><name><surname>Stephens</surname><given-names>M.</given-names></name><name><surname>Ober</surname><given-names>C.</given-names></name><name><surname>Przeworski</surname><given-names>M.</given-names></name></person-group>, <year>2015</year> <article-title>An estimate of the average number of recessive lethal mutations carried by humans.</article-title>
<source/>Genetics
<volume>199</volume>: <fpage>1243</fpage>–<lpage>1254</lpage>.<pub-id pub-id-type="pmid">25697177</pub-id></mixed-citation>
</ref>
<ref id="bib51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garg</surname><given-names>A.</given-names></name><name><surname>Kircher</surname><given-names>M.</given-names></name><name><surname>Del Campo</surname><given-names>M.</given-names></name><name><surname>Amato</surname><given-names>R. S.</given-names></name><name><surname>Agarwal</surname><given-names>A. K.</given-names></name><etal></etal></person-group>, <year>2015</year> <article-title>Whole exome sequencing identifies de novo heterozygous CAV1 mutations associated with a novel neonatal onset lipodystrophy syndrome.</article-title>
<source/>Am. J. Med. Genet. A.
<volume>167A</volume>: <fpage>1796</fpage>–<lpage>1806</lpage>.<pub-id pub-id-type="pmid">25898808</pub-id></mixed-citation>
</ref>
<ref id="bib52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrod</surname><given-names>A. E.</given-names></name></person-group>, <year>1902</year> <article-title>The incidence of alkaptonuria: a study in chemical individuality.</article-title>
<source/>Lancet
<volume>ii</volume>: <fpage>1616</fpage>–<lpage>1620</lpage>.</mixed-citation>
</ref>
<ref id="bib53">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Garrod</surname><given-names>A. E.</given-names></name></person-group>, <year>1923</year> <source/>Inborn Errors of Metabolism. <publisher-name>Henry Frowde and Hodder &amp; Stoughton</publisher-name>, <publisher-loc>London</publisher-loc>.</mixed-citation>
</ref>
<ref id="bib54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gee</surname><given-names>H. Y.</given-names></name><name><surname>Sadowski</surname><given-names>C. E.</given-names></name><name><surname>Aggarwal</surname><given-names>P. K.</given-names></name><name><surname>Porath</surname><given-names>J. D.</given-names></name><name><surname>Yakulov</surname><given-names>T. A.</given-names></name><etal></etal></person-group>, <year>2016</year> <article-title>FAT1 mutations cause a glomerulotubular nephropathy.</article-title>
<source/>Nat. Commun.
<volume>7</volume>: <fpage>10822</fpage>.<pub-id pub-id-type="pmid">26905694</pub-id></mixed-citation>
</ref>
<ref id="bib55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzaga-Jauregui</surname><given-names>C.</given-names></name><name><surname>Lupski</surname><given-names>J. R.</given-names></name><name><surname>Gibbs</surname><given-names>R. A.</given-names></name></person-group>, <year>2012</year> <article-title>Human genome sequencing in health and disease.</article-title>
<source/>Annu. Rev. Med.
<volume>63</volume>: <fpage>35</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="pmid">22248320</pub-id></mixed-citation>
</ref>
<ref id="bib56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname><given-names>K. A.</given-names></name><name><surname>Yates</surname><given-names>B.</given-names></name><name><surname>Seal</surname><given-names>R. L.</given-names></name><name><surname>Wright</surname><given-names>M. W.</given-names></name><name><surname>Bruford</surname><given-names>E. A.</given-names></name></person-group>, <year>2015</year> <article-title>Genenames.org: the HGNC resources in 2015.</article-title>
<source/>Nucleic Acids Res.
<volume>43</volume>: <fpage>D1079</fpage>–<lpage>D1085</lpage>.<pub-id pub-id-type="pmid">25361968</pub-id></mixed-citation>
</ref>
<ref id="bib57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halder</surname><given-names>G.</given-names></name><name><surname>Johnson</surname><given-names>R. L.</given-names></name></person-group>, <year>2011</year> <article-title>Hippo signaling: growth control and beyond.</article-title>
<source/>Development
<volume>138</volume>: <fpage>9</fpage>–<lpage>22</lpage>.<pub-id pub-id-type="pmid">21138973</pub-id></mixed-citation>
</ref>
<ref id="bib58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamosh</surname><given-names>A.</given-names></name><name><surname>Sobreira</surname><given-names>N.</given-names></name><name><surname>Hoover-Fong</surname><given-names>J.</given-names></name><name><surname>Sutton</surname><given-names>V. R.</given-names></name><name><surname>Boehm</surname><given-names>C.</given-names></name><etal></etal></person-group>, <year>2013</year> <article-title>PhenoDB: a new web-based tool for the collection, storage, and analysis of phenotypic features.</article-title>
<source/>Hum. Mutat.
<volume>34</volume>: <fpage>566</fpage>–<lpage>571</lpage>.<pub-id pub-id-type="pmid">23378291</pub-id></mixed-citation>
</ref>
<ref id="bib59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamza</surname><given-names>A.</given-names></name><name><surname>Tammpere</surname><given-names>E.</given-names></name><name><surname>Kofoed</surname><given-names>M.</given-names></name><name><surname>Keong</surname><given-names>C.</given-names></name><name><surname>Chiang</surname><given-names>J.</given-names></name><etal></etal></person-group>, <year>2015</year> <article-title>Complementation of yeast genes with human genes as an experimental platform for functional testing of human genetic variants.</article-title>
<source/>Genetics
<volume>201</volume>: <fpage>1263</fpage>–<lpage>1274</lpage>.<pub-id pub-id-type="pmid">26354769</pub-id></mixed-citation>
</ref>
<ref id="bib60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harel</surname><given-names>T.</given-names></name><name><surname>Yesil</surname><given-names>G.</given-names></name><name><surname>Bayram</surname><given-names>Y.</given-names></name><name><surname>Coban-Akdemir</surname><given-names>Z.</given-names></name><name><surname>Charng</surname><given-names>W. L.</given-names></name><etal></etal></person-group>, <year>2016</year><comment>a</comment> <article-title>Monoallelic and biallelic variants in EMC1 identified in individuals with global developmental delay, hypotonia, scoliosis, and cerebellar atrophy.</article-title>
<source/>Am. J. Hum. Genet.
<volume>98</volume>: <fpage>562</fpage>–<lpage>570</lpage>.<pub-id pub-id-type="pmid">26942288</pub-id></mixed-citation>
</ref>
<ref id="bib61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harel</surname><given-names>T.</given-names></name><name><surname>Yoon</surname><given-names>W. H.</given-names></name><name><surname>Garone</surname><given-names>C.</given-names></name><name><surname>Gu</surname><given-names>S.</given-names></name><name><surname>Coban-Akdemir</surname><given-names>Z.</given-names></name><etal></etal></person-group>, <year>2016</year><comment>b</comment> <article-title>Recurrent de novo and biallelic variation of ATAD3A, encoding a mitochondrial membrane protein, results in distinct neurological syndromes.</article-title>
<source/>Am. J. Hum. Genet.
<volume>99</volume>: <fpage>831</fpage>–<lpage>845</lpage>.<pub-id pub-id-type="pmid">27640307</pub-id></mixed-citation>
</ref>
<ref id="bib62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harms</surname><given-names>F. L.</given-names></name><name><surname>Girisha</surname><given-names>K. M.</given-names></name><name><surname>Hardigan</surname><given-names>A. A.</given-names></name><name><surname>Kortum</surname><given-names>F.</given-names></name><name><surname>Shukla</surname><given-names>A.</given-names></name><etal></etal></person-group>, <year>2017</year> <article-title>Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia, and facial dysmorphism.</article-title>
<source/>Am. J. Hum. Genet.
<volume>100</volume>: <fpage>117</fpage>–<lpage>127</lpage>.<pub-id pub-id-type="pmid">28017373</pub-id></mixed-citation>
</ref>
<ref id="bib63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartwell</surname><given-names>L. H.</given-names></name><name><surname>Culotti</surname><given-names>J.</given-names></name><name><surname>Reid</surname><given-names>B.</given-names></name></person-group>, <year>1970</year> <article-title>Genetic control of the cell-division cycle in yeast. I. Detection of mutants.</article-title>
<source/>Proc. Natl. Acad. Sci. USA
<volume>66</volume>: <fpage>352</fpage>–<lpage>359</lpage>.<pub-id pub-id-type="pmid">5271168</pub-id></mixed-citation>
</ref>
<ref id="bib64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartwell</surname><given-names>L. H.</given-names></name><name><surname>Culotti</surname><given-names>J.</given-names></name><name><surname>Pringle</surname><given-names>J. R.</given-names></name><name><surname>Reid</surname><given-names>B. J.</given-names></name></person-group>, <year>1974</year> <article-title>Genetic control of the cell division cycle in yeast.</article-title>
<source/>Science
<volume>183</volume>: <fpage>46</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="pmid">4587263</pub-id></mixed-citation>
</ref>
<ref id="bib65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hieter</surname><given-names>P.</given-names></name><name><surname>Boycott</surname><given-names>K. M.</given-names></name></person-group>, <year>2014</year> <article-title>Understanding rare disease pathogenesis: a grand challenge for model organisms.</article-title>
<source/>Genetics
<volume>198</volume>: <fpage>443</fpage>–<lpage>445</lpage>.<pub-id pub-id-type="pmid">25316782</pub-id></mixed-citation>
</ref>
<ref id="bib66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holland</surname><given-names>P. W.</given-names></name><name><surname>Garcia-Fernandez</surname><given-names>J.</given-names></name><name><surname>Williams</surname><given-names>N. A.</given-names></name><name><surname>Sidow</surname><given-names>A.</given-names></name></person-group>, <year>1994</year> <article-title>Gene duplications and the origins of vertebrate development.</article-title>
<source/>Dev. Suppl.
<volume>120</volume>: <fpage>125</fpage>–<lpage>133</lpage>.</mixed-citation>
</ref>
<ref id="bib67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howe</surname><given-names>D. G.</given-names></name><name><surname>Bradford</surname><given-names>Y. M.</given-names></name><name><surname>Eagle</surname><given-names>A.</given-names></name><name><surname>Fashena</surname><given-names>D.</given-names></name><name><surname>Frazer</surname><given-names>K.</given-names></name><etal></etal></person-group>, <year>2017</year> <article-title>The zebrafish model organism database: new support for human disease models, mutation details, gene expression phenotypes and searching.</article-title>
<source/>Nucleic Acids Res.
<volume>45</volume>: <fpage>D758</fpage>–<lpage>D768</lpage>.<pub-id pub-id-type="pmid">27899582</pub-id></mixed-citation>
</ref>
<ref id="bib68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howe</surname><given-names>K.</given-names></name><name><surname>Clark</surname><given-names>M. D.</given-names></name><name><surname>Torroja</surname><given-names>C. F.</given-names></name><name><surname>Torrance</surname><given-names>J.</given-names></name><name><surname>Berthelot</surname><given-names>C.</given-names></name><etal></etal></person-group>, <year>2013</year> <article-title>The zebrafish reference genome sequence and its relationship to the human genome.</article-title>
<source/>Nature
<volume>496</volume>: <fpage>498</fpage>–<lpage>503</lpage>.<pub-id pub-id-type="pmid">23594743</pub-id></mixed-citation>
</ref>
<ref id="bib69">
<mixed-citation publication-type="book"><person-group person-group-type="author"><collab>IOM</collab></person-group>, <year>2010</year> <source/>Rare Diseases and Orphan Products: Accelerating Research and Development. <publisher-name>National Academies Press</publisher-name>, <publisher-loc>Washington, DC</publisher-loc>.</mixed-citation>
</ref>
<ref id="bib70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>R. A.</given-names></name><name><surname>Campbell</surname><given-names>I. M.</given-names></name><name><surname>Chen</surname><given-names>E. S.</given-names></name><name><surname>Boone</surname><given-names>P. M.</given-names></name><name><surname>Rao</surname><given-names>M. A.</given-names></name><etal></etal></person-group>, <year>2016</year> <article-title>A visual and curatorial approach to clinical variant prioritization and disease gene discovery in genome-wide diagnostics.</article-title>
<source/>Genome Med.
<volume>8</volume>: <fpage>13</fpage>.<pub-id pub-id-type="pmid">26838676</pub-id></mixed-citation>
</ref>
<ref id="bib71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jarman</surname><given-names>A. P.</given-names></name><name><surname>Grau</surname><given-names>Y.</given-names></name><name><surname>Jan</surname><given-names>L. Y.</given-names></name><name><surname>Jan</surname><given-names>Y. N.</given-names></name></person-group>, <year>1993</year> <article-title>atonal is a proneural gene that directs chordotonal organ formation in the Drosophila peripheral nervous system.</article-title>
<source/>Cell
<volume>73</volume>: <fpage>1307</fpage>–<lpage>1321</lpage>.<pub-id pub-id-type="pmid">8324823</pub-id></mixed-citation>
</ref>
<ref id="bib72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kachroo</surname><given-names>A. H.</given-names></name><name><surname>Laurent</surname><given-names>J. M.</given-names></name><name><surname>Yellman</surname><given-names>C. M.</given-names></name><name><surname>Meyer</surname><given-names>A. G.</given-names></name><name><surname>Wilke</surname><given-names>C. O.</given-names></name><etal></etal></person-group>, <year>2015</year> <article-title>Evolution. Systematic humanization of yeast genes reveals conserved functions and genetic modularity.</article-title>
<source/>Science
<volume>348</volume>: <fpage>921</fpage>–<lpage>925</lpage>.<pub-id pub-id-type="pmid">25999509</pub-id></mixed-citation>
</ref>
<ref id="bib73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kandel</surname><given-names>E. R.</given-names></name></person-group>, <year>2001</year> <article-title>The molecular biology of memory storage: a dialogue between genes and synapses.</article-title>
<source/>Science
<volume>294</volume>: <fpage>1030</fpage>–<lpage>1038</lpage>.<pub-id pub-id-type="pmid">11691980</pub-id></mixed-citation>
</ref>
<ref id="bib74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karaca</surname><given-names>E.</given-names></name><name><surname>Weitzer</surname><given-names>S.</given-names></name><name><surname>Pehlivan</surname><given-names>D.</given-names></name><name><surname>Shiraishi</surname><given-names>H.</given-names></name><name><surname>Gogakos</surname><given-names>T.</given-names></name><etal></etal></person-group>, <year>2014</year> <article-title>Human CLP1 mutations alter tRNA biogenesis, affecting both peripheral and central nervous system function.</article-title>
<source/>Cell
<volume>157</volume>: <fpage>636</fpage>–<lpage>650</lpage>.<pub-id pub-id-type="pmid">24766809</pub-id></mixed-citation>
</ref>
<ref id="bib75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kremer</surname><given-names>L. S.</given-names></name><name><surname>Distelmaier</surname><given-names>F.</given-names></name><name><surname>Alhaddad</surname><given-names>B.</given-names></name><name><surname>Hempel</surname><given-names>M.</given-names></name><name><surname>Iuso</surname><given-names>A.</given-names></name><etal></etal></person-group>, <year>2016</year> <article-title>Bi-allelic truncating mutations in TANGO2 cause infancy-onset recurrent metabolic crises with encephalocardiomyopathy.</article-title>
<source/>Am. J. Hum. Genet.
<volume>98</volume>: <fpage>358</fpage>–<lpage>362</lpage>.<pub-id pub-id-type="pmid">26805782</pub-id></mixed-citation>
</ref>
<ref id="bib76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuang</surname><given-names>S. Q.</given-names></name><name><surname>Medina-Martinez</surname><given-names>O.</given-names></name><name><surname>Guo</surname><given-names>D. C.</given-names></name><name><surname>Gong</surname><given-names>L.</given-names></name><name><surname>Regalado</surname><given-names>E. S.</given-names></name><etal></etal></person-group>, <year>2016</year> <article-title>FOXE3 mutations predispose to thoracic aortic aneurysms and dissections.</article-title>
<source/>J. Clin. Invest.
<volume>126</volume>: <fpage>948</fpage>–<lpage>961</lpage>.<pub-id pub-id-type="pmid">26854927</pub-id></mixed-citation>
</ref>
<ref id="bib77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lalani</surname><given-names>S. R.</given-names></name><name><surname>Liu</surname><given-names>P.</given-names></name><name><surname>Rosenfeld</surname><given-names>J. A.</given-names></name><name><surname>Watkin</surname><given-names>L. B.</given-names></name><name><surname>Chiang</surname><given-names>T.</given-names></name><etal></etal></person-group>, <year>2016</year> <article-title>Recurrent muscle weakness with rhabdomyolysis, metabolic crises, and cardiac arrhythmia due to bi-allelic TANGO2 mutations.</article-title>
<source/>Am. J. Hum. Genet.
<volume>98</volume>: <fpage>347</fpage>–<lpage>357</lpage>.<pub-id pub-id-type="pmid">26805781</pub-id></mixed-citation>
</ref>
<ref id="bib78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landoure</surname><given-names>G.</given-names></name><name><surname>Zdebik</surname><given-names>A. A.</given-names></name><name><surname>Martinez</surname><given-names>T. L.</given-names></name><name><surname>Burnett</surname><given-names>B. G.</given-names></name><name><surname>Stanescu</surname><given-names>H. C.</given-names></name><etal></etal></person-group>, <year>2010</year> <article-title>Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C.</article-title>
<source/>Nat. Genet.
<volume>42</volume>: <fpage>170</fpage>–<lpage>174</lpage>.<pub-id pub-id-type="pmid">20037586</pub-id></mixed-citation>
</ref>
<ref id="bib79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Law</surname><given-names>R.</given-names></name><name><surname>Dixon-Salazar</surname><given-names>T.</given-names></name><name><surname>Jerber</surname><given-names>J.</given-names></name><name><surname>Cai</surname><given-names>N.</given-names></name><name><surname>Abbasi</surname><given-names>A. A.</given-names></name><etal></etal></person-group>, <year>2014</year> <article-title>Biallelic truncating mutations in FMN2, encoding the actin-regulatory protein Formin 2, cause nonsyndromic autosomal-recessive intellectual disability.</article-title>
<source/>Am. J. Hum. Genet.
<volume>95</volume>: <fpage>721</fpage>–<lpage>728</lpage>.<pub-id pub-id-type="pmid">25480035</pub-id></mixed-citation>
</ref>
<ref id="bib80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>H.</given-names></name><name><surname>Deignan</surname><given-names>J. L.</given-names></name><name><surname>Dorrani</surname><given-names>N.</given-names></name><name><surname>Strom</surname><given-names>S. P.</given-names></name><name><surname>Kantarci</surname><given-names>S.</given-names></name><etal></etal></person-group>, <year>2014</year> <article-title>Clinical exome sequencing for genetic identification of rare Mendelian disorders.</article-title>
<source/>JAMA
<volume>312</volume>: <fpage>1880</fpage>–<lpage>1887</lpage>.<pub-id pub-id-type="pmid">25326637</pub-id></mixed-citation>
</ref>
<ref id="bib81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehner</surname><given-names>B.</given-names></name></person-group>, <year>2013</year> <article-title>Genotype to phenotype: lessons from model organisms for human genetics.</article-title>
<source/>Nat. Rev. Genet.
<volume>14</volume>: <fpage>168</fpage>–<lpage>178</lpage>.<pub-id pub-id-type="pmid">23358379</pub-id></mixed-citation>
</ref>
<ref id="bib82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lek</surname><given-names>M.</given-names></name><name><surname>Karczewski</surname><given-names>K. J.</given-names></name><name><surname>Minikel</surname><given-names>E. V.</given-names></name><name><surname>Samocha</surname><given-names>K. E.</given-names></name><name><surname>Banks</surname><given-names>E.</given-names></name><etal></etal></person-group>, <year>2016</year> <article-title>Analysis of protein-coding genetic variation in 60,706 humans.</article-title>
<source/>Nature
<volume>536</volume>: <fpage>285</fpage>–<lpage>291</lpage>.<pub-id pub-id-type="pmid">27535533</pub-id></mixed-citation>
</ref>
<ref id="bib83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemaitre</surname><given-names>B.</given-names></name><name><surname>Nicolas</surname><given-names>E.</given-names></name><name><surname>Michaut</surname><given-names>L.</given-names></name><name><surname>Reichhart</surname><given-names>J. M.</given-names></name><name><surname>Hoffmann</surname><given-names>J. A.</given-names></name></person-group>, <year>1996</year> <article-title>The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults.</article-title>
<source/>Cell
<volume>86</volume>: <fpage>973</fpage>–<lpage>983</lpage>.<pub-id pub-id-type="pmid">8808632</pub-id></mixed-citation>
</ref>
<ref id="bib84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>S.</given-names></name><name><surname>Sutton</surname><given-names>G.</given-names></name><name><surname>Ng</surname><given-names>P. C.</given-names></name><name><surname>Feuk</surname><given-names>L.</given-names></name><name><surname>Halpern</surname><given-names>A. L.</given-names></name><etal></etal></person-group>, <year>2007</year> <article-title>The diploid genome sequence of an individual human.</article-title>
<source/>PLoS Biol.
<volume>5</volume>: <fpage>e254</fpage>.<pub-id pub-id-type="pmid">17803354</pub-id></mixed-citation>
</ref>
<ref id="bib85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>E. B.</given-names></name></person-group>, <year>1978</year> <article-title>A gene complex controlling segmentation in Drosophila.</article-title>
<source/>Nature
<volume>276</volume>: <fpage>565</fpage>–<lpage>570</lpage>.<pub-id pub-id-type="pmid">103000</pub-id></mixed-citation>
</ref>
<ref id="bib86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Meng</surname><given-names>T.</given-names></name><name><surname>Jia</surname><given-names>Z.</given-names></name><name><surname>Zhu</surname><given-names>G.</given-names></name><name><surname>Shi</surname><given-names>B.</given-names></name></person-group>, <year>2010</year> <article-title>Single nucleotide polymorphism associated with nonsyndromic cleft palate influences the processing of miR-140.</article-title>
<source/>Am. J. Med. Genet. A.
<volume>152A</volume>: <fpage>856</fpage>–<lpage>862</lpage>.<pub-id pub-id-type="pmid">20358594</pub-id></mixed-citation>
</ref>
<ref id="bib87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>W. M.</given-names></name><name><surname>Baker</surname><given-names>A. C.</given-names></name><name><surname>Beroukhim</surname><given-names>R.</given-names></name><name><surname>Winckler</surname><given-names>W.</given-names></name><name><surname>Feng</surname><given-names>W.</given-names></name><etal></etal></person-group>, <year>2008</year> <article-title>Modeling genomic diversity and tumor dependency in malignant melanoma.</article-title>
<source/>Cancer Res.
<volume>68</volume>: <fpage>664</fpage>–<lpage>673</lpage>.<pub-id pub-id-type="pmid">18245465</pub-id></mixed-citation>
</ref>
<ref id="bib88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lupski</surname><given-names>J. R.</given-names></name><name><surname>Reid</surname><given-names>J. G.</given-names></name><name><surname>Gonzaga-Jauregui</surname><given-names>C.</given-names></name><name><surname>Rio Deiros</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>D. C.</given-names></name><etal></etal></person-group>, <year>2010</year> <article-title>Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy.</article-title>
<source/>N. Engl. J. Med.
<volume>362</volume>: <fpage>1181</fpage>–<lpage>1191</lpage>.<pub-id pub-id-type="pmid">20220177</pub-id></mixed-citation>
</ref>
<ref id="bib89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lupski</surname><given-names>J. R.</given-names></name><name><surname>Belmont</surname><given-names>J. W.</given-names></name><name><surname>Boerwinkle</surname><given-names>E.</given-names></name><name><surname>Gibbs</surname><given-names>R. A.</given-names></name></person-group>, <year>2011</year> <article-title>Clan genomics and the complex architecture of human disease.</article-title>
<source/>Cell
<volume>147</volume>: <fpage>32</fpage>–<lpage>43</lpage>.<pub-id pub-id-type="pmid">21962505</pub-id></mixed-citation>
</ref>
<ref id="bib90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macgregor</surname><given-names>S.</given-names></name><name><surname>Montgomery</surname><given-names>G. W.</given-names></name><name><surname>Liu</surname><given-names>J. Z.</given-names></name><name><surname>Zhao</surname><given-names>Z. Z.</given-names></name><name><surname>Henders</surname><given-names>A. K.</given-names></name><etal></etal></person-group>, <year>2011</year> <article-title>Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3.</article-title>
<source/>Nat. Genet.
<volume>43</volume>: <fpage>1114</fpage>–<lpage>1118</lpage>.<pub-id pub-id-type="pmid">21983785</pub-id></mixed-citation>
</ref>
<ref id="bib91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manolio</surname><given-names>T. A.</given-names></name><name><surname>Fowler</surname><given-names>D. M.</given-names></name><name><surname>Starita</surname><given-names>L. M.</given-names></name><name><surname>Haendel</surname><given-names>M. A.</given-names></name><name><surname>MacArthur</surname><given-names>D. G.</given-names></name><etal></etal></person-group>, <year>2017</year> <article-title>Bedside back to bench: building bridges between basic and clinical genomic research.</article-title>
<source/>Cell
<volume>169</volume>: <fpage>6</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="pmid">28340351</pub-id></mixed-citation>
</ref>
<ref id="bib92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markello</surname><given-names>T. C.</given-names></name><name><surname>Pak</surname><given-names>L. K.</given-names></name><name><surname>St Hilaire</surname><given-names>C.</given-names></name><name><surname>Dorward</surname><given-names>H.</given-names></name><name><surname>Ziegler</surname><given-names>S. G.</given-names></name><etal></etal></person-group>, <year>2011</year> <article-title>Vascular pathology of medial arterial calcifications in NT5E deficiency: implications for the role of adenosine in pseudoxanthoma elasticum.</article-title>
<source/>Mol. Genet. Metab.
<volume>103</volume>: <fpage>44</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">21371928</pub-id></mixed-citation>
</ref>
<ref id="bib93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayor</surname><given-names>R.</given-names></name><name><surname>Theveneau</surname><given-names>E.</given-names></name></person-group>, <year>2013</year> <article-title>The neural crest.</article-title>
<source/>Development
<volume>140</volume>: <fpage>2247</fpage>–<lpage>2251</lpage>.<pub-id pub-id-type="pmid">23674598</pub-id></mixed-citation>
</ref>
<ref id="bib94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarroll</surname><given-names>S. A.</given-names></name><name><surname>Huett</surname><given-names>A.</given-names></name><name><surname>Kuballa</surname><given-names>P.</given-names></name><name><surname>Chilewski</surname><given-names>S. D.</given-names></name><name><surname>Landry</surname><given-names>A.</given-names></name><etal></etal></person-group>, <year>2008</year> <article-title>Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn’s disease.</article-title>
<source/>Nat. Genet.
<volume>40</volume>: <fpage>1107</fpage>–<lpage>1112</lpage>.<pub-id pub-id-type="pmid">19165925</pub-id></mixed-citation>
</ref>
<ref id="bib95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGary</surname><given-names>K. L.</given-names></name><name><surname>Park</surname><given-names>T. J.</given-names></name><name><surname>Woods</surname><given-names>J. O.</given-names></name><name><surname>Cha</surname><given-names>H. J.</given-names></name><name><surname>Wallingford</surname><given-names>J. B.</given-names></name><etal></etal></person-group>, <year>2011</year> <article-title>Systematic discovery of nonobvious human disease models through orthologous phenotypes.</article-title>
<source/>Proc. Natl. Acad. Sci. USA
<volume>107</volume>: <fpage>6544</fpage>–<lpage>6549</lpage>.</mixed-citation>
</ref>
<ref id="bib96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGurk</surname><given-names>L.</given-names></name><name><surname>Berson</surname><given-names>A.</given-names></name><name><surname>Bonini</surname><given-names>N. M.</given-names></name></person-group>, <year>2015</year> <article-title>Drosophila as an in vivo model for human neurodegenerative disease.</article-title>
<source/>Genetics
<volume>201</volume>: <fpage>377</fpage>–<lpage>402</lpage>.<pub-id pub-id-type="pmid">26447127</pub-id></mixed-citation>
</ref>
<ref id="bib97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra-Gorur</surname><given-names>K.</given-names></name><name><surname>Caglayan</surname><given-names>A. O.</given-names></name><name><surname>Schaffer</surname><given-names>A. E.</given-names></name><name><surname>Chabu</surname><given-names>C.</given-names></name><name><surname>Henegariu</surname><given-names>O.</given-names></name><etal></etal></person-group>, <year>2014</year> <article-title>Mutations in KATNB1 cause complex cerebral malformations by disrupting asymmetrically dividing neural progenitors.</article-title>
<source/>Neuron
<volume>84</volume>: <fpage>1226</fpage>–<lpage>1239</lpage>.<pub-id pub-id-type="pmid">25521378</pub-id></mixed-citation>
</ref>
<ref id="bib98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizushima</surname><given-names>N.</given-names></name><name><surname>Noda</surname><given-names>T.</given-names></name><name><surname>Yoshimori</surname><given-names>T.</given-names></name><name><surname>Tanaka</surname><given-names>Y.</given-names></name><name><surname>Ishii</surname><given-names>T.</given-names></name><etal></etal></person-group>, <year>1998</year> <article-title>A protein conjugation system essential for autophagy.</article-title>
<source/>Nature
<volume>395</volume>: <fpage>395</fpage>–<lpage>398</lpage>.<pub-id pub-id-type="pmid">9759731</pub-id></mixed-citation>
</ref>
<ref id="bib99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montell</surname><given-names>C.</given-names></name></person-group>, <year>2005</year> <article-title>Drosophila TRP channels.</article-title>
<source/>Pflugers Arch.
<volume>451</volume>: <fpage>19</fpage>–<lpage>28</lpage>.<pub-id pub-id-type="pmid">15952038</pub-id></mixed-citation>
</ref>
<ref id="bib100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagarkar-Jaiswal</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>P. T.</given-names></name><name><surname>Campbell</surname><given-names>M. E.</given-names></name><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Anguiano-Zarate</surname><given-names>S.</given-names></name><etal></etal></person-group>, <year>2015</year> <article-title>A library of MiMICs allows tagging of genes and reversible, spatial and temporal knockdown of proteins in Drosophila.</article-title>
<source/>Elife
<volume>4</volume>: <fpage>e05338</fpage>.</mixed-citation>
</ref>
<ref id="bib101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Need</surname><given-names>A. C.</given-names></name><name><surname>Shashi</surname><given-names>V.</given-names></name><name><surname>Hitomi</surname><given-names>Y.</given-names></name><name><surname>Schoch</surname><given-names>K.</given-names></name><name><surname>Shianna</surname><given-names>K. V.</given-names></name><etal></etal></person-group>, <year>2012</year> <article-title>Clinical application of exome sequencing in undiagnosed genetic conditions.</article-title>
<source/>J. Med. Genet.
<volume>49</volume>: <fpage>353</fpage>–<lpage>361</lpage>.<pub-id pub-id-type="pmid">22581936</pub-id></mixed-citation>
</ref>
<ref id="bib102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nilius</surname><given-names>B.</given-names></name><name><surname>Owsianik</surname><given-names>G.</given-names></name></person-group>, <year>2010</year> <article-title>Channelopathies converge on TRPV4.</article-title>
<source/>Nat. Genet.
<volume>42</volume>: <fpage>98</fpage>–<lpage>100</lpage>.<pub-id pub-id-type="pmid">20104247</pub-id></mixed-citation>
</ref>
<ref id="bib103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishimura</surname><given-names>G.</given-names></name><name><surname>Lausch</surname><given-names>E.</given-names></name><name><surname>Savarirayan</surname><given-names>R.</given-names></name><name><surname>Shiba</surname><given-names>M.</given-names></name><name><surname>Spranger</surname><given-names>J.</given-names></name><etal></etal></person-group>, <year>2012</year> <article-title>TRPV4-associated skeletal dysplasias.</article-title>
<source/>Am. J. Med. Genet. C. Semin. Med. Genet.
<volume>160C</volume>: <fpage>190</fpage>–<lpage>204</lpage>.<pub-id pub-id-type="pmid">22791502</pub-id></mixed-citation>
</ref>
<ref id="bib104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novick</surname><given-names>P.</given-names></name><name><surname>Field</surname><given-names>C.</given-names></name><name><surname>Schekman</surname><given-names>R.</given-names></name></person-group>, <year>1980</year> <article-title>Identification of 23 complementation groups required for post-translational events in the yeast secretory pathway.</article-title>
<source/>Cell
<volume>21</volume>: <fpage>205</fpage>–<lpage>215</lpage>.<pub-id pub-id-type="pmid">6996832</pub-id></mixed-citation>
</ref>
<ref id="bib105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nurse</surname><given-names>P.</given-names></name><name><surname>Bissett</surname><given-names>Y.</given-names></name></person-group>, <year>1981</year> <article-title>Gene required in G1 for commitment to cell cycle and in G2 for control of mitosis in fission yeast.</article-title>
<source/>Nature
<volume>292</volume>: <fpage>558</fpage>–<lpage>560</lpage>.<pub-id pub-id-type="pmid">7254352</pub-id></mixed-citation>
</ref>
<ref id="bib106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nusslein-Volhard</surname><given-names>C.</given-names></name><name><surname>Wieschaus</surname><given-names>E.</given-names></name></person-group>, <year>1980</year> <article-title>Mutations affecting segment number and polarity in Drosophila.</article-title>
<source/>Nature
<volume>287</volume>: <fpage>795</fpage>–<lpage>801</lpage>.<pub-id pub-id-type="pmid">6776413</pub-id></mixed-citation>
</ref>
<ref id="bib107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Person</surname><given-names>A. D.</given-names></name><name><surname>Beiraghi</surname><given-names>S.</given-names></name><name><surname>Sieben</surname><given-names>C. M.</given-names></name><name><surname>Hermanson</surname><given-names>S.</given-names></name><name><surname>Neumann</surname><given-names>A. N.</given-names></name><etal></etal></person-group>, <year>2010</year> <article-title>WNT5A mutations in patients with autosomal dominant Robinow syndrome.</article-title>
<source/>Dev. Dyn.
<volume>239</volume>: <fpage>327</fpage>–<lpage>337</lpage>.<pub-id pub-id-type="pmid">19918918</pub-id></mixed-citation>
</ref>
<ref id="bib108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philippakis</surname><given-names>A. A.</given-names></name><name><surname>Azzariti</surname><given-names>D. R.</given-names></name><name><surname>Beltran</surname><given-names>S.</given-names></name><name><surname>Brookes</surname><given-names>A. J.</given-names></name><name><surname>Brownstein</surname><given-names>C. A.</given-names></name><etal></etal></person-group>, <year>2015</year> <article-title>The matchmaker exchange: a platform for rare disease gene discovery.</article-title>
<source/>Hum. Mutat.
<volume>36</volume>: <fpage>915</fpage>–<lpage>921</lpage>.<pub-id pub-id-type="pmid">26295439</pub-id></mixed-citation>
</ref>
<ref id="bib109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>J. B.</given-names></name><name><surname>Westerfield</surname><given-names>M.</given-names></name></person-group>, <year>2014</year> <article-title>Zebrafish models in translational research: tipping the scales toward advancements in human health.</article-title>
<source/>Dis. Model. Mech.
<volume>7</volume>: <fpage>739</fpage>–<lpage>743</lpage>.<pub-id pub-id-type="pmid">24973743</pub-id></mixed-citation>
</ref>
<ref id="bib110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierson</surname><given-names>T. M.</given-names></name><name><surname>Adams</surname><given-names>D.</given-names></name><name><surname>Bonn</surname><given-names>F.</given-names></name><name><surname>Martinelli</surname><given-names>P.</given-names></name><name><surname>Cherukuri</surname><given-names>P. F.</given-names></name><etal></etal></person-group>, <year>2011</year> <article-title>Whole-exome sequencing identifies homozygous AFG3L2 mutations in a spastic ataxia-neuropathy syndrome linked to mitochondrial m-AAA proteases.</article-title>
<source/>PLoS Genet.
<volume>7</volume>: <fpage>e1002325</fpage>.<pub-id pub-id-type="pmid">22022284</pub-id></mixed-citation>
</ref>
<ref id="bib111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollock</surname><given-names>P. M.</given-names></name><name><surname>Harper</surname><given-names>U. L.</given-names></name><name><surname>Hansen</surname><given-names>K. S.</given-names></name><name><surname>Yudt</surname><given-names>L. M.</given-names></name><name><surname>Stark</surname><given-names>M.</given-names></name><etal></etal></person-group>, <year>2003</year> <article-title>High frequency of BRAF mutations in nevi.</article-title>
<source/>Nat. Genet.
<volume>33</volume>: <fpage>19</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="pmid">12447372</pub-id></mixed-citation>
</ref>
<ref id="bib112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Posey</surname><given-names>J. E.</given-names></name><name><surname>Rosenfeld</surname><given-names>J. A.</given-names></name><name><surname>James</surname><given-names>R. A.</given-names></name><name><surname>Bainbridge</surname><given-names>M.</given-names></name><name><surname>Niu</surname><given-names>Z.</given-names></name><etal></etal></person-group>, <year>2016</year> <article-title>Molecular diagnostic experience of whole-exome sequencing in adult patients.</article-title>
<source/>Genet. Med.
<volume>18</volume>: <fpage>678</fpage>–<lpage>685</lpage>.<pub-id pub-id-type="pmid">26633545</pub-id></mixed-citation>
</ref>
<ref id="bib113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramoni</surname><given-names>R. B.</given-names></name><name><surname>Mulvihill</surname><given-names>J. J.</given-names></name><name><surname>Adams</surname><given-names>D. R.</given-names></name><name><surname>Allard</surname><given-names>P.</given-names></name><name><surname>Ashley</surname><given-names>E. A.</given-names></name><etal></etal></person-group>, <year>2017</year> <article-title>The undiagnosed diseases network: accelerating discovery about health and disease.</article-title>
<source/>Am. J. Hum. Genet.
<volume>100</volume>: <fpage>185</fpage>–<lpage>192</lpage>.<pub-id pub-id-type="pmid">28157539</pub-id></mixed-citation>
</ref>
<ref id="bib114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Retterer</surname><given-names>K.</given-names></name><name><surname>Juusola</surname><given-names>J.</given-names></name><name><surname>Cho</surname><given-names>M. T.</given-names></name><name><surname>Vitazka</surname><given-names>P.</given-names></name><name><surname>Millan</surname><given-names>F.</given-names></name><etal></etal></person-group>, <year>2016</year> <article-title>Clinical application of whole-exome sequencing across clinical indications.</article-title>
<source/>Genet. Med.
<volume>18</volume>: <fpage>696</fpage>–<lpage>704</lpage>.<pub-id pub-id-type="pmid">26633542</pub-id></mixed-citation>
</ref>
<ref id="bib115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>J. J.</given-names></name><name><surname>Theriot</surname><given-names>J. A.</given-names></name><name><surname>Sood</surname><given-names>P.</given-names></name><name><surname>Marshall</surname><given-names>W. F.</given-names></name><name><surname>Landweber</surname><given-names>L. F.</given-names></name><etal></etal></person-group>, <year>2017</year> <article-title>Non-model model organisms.</article-title>
<source/>BMC Biol.
<volume>15</volume>: <fpage>55</fpage>.<pub-id pub-id-type="pmid">28662661</pub-id></mixed-citation>
</ref>
<ref id="bib116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarov</surname><given-names>M.</given-names></name><name><surname>Barz</surname><given-names>C.</given-names></name><name><surname>Jambor</surname><given-names>H.</given-names></name><name><surname>Hein</surname><given-names>M. Y.</given-names></name><name><surname>Schmied</surname><given-names>C.</given-names></name><etal></etal></person-group>, <year>2016</year> <article-title>A genome-wide resource for the analysis of protein localisation in Drosophila.</article-title>
<source/>Elife
<volume>5</volume>: <fpage>e12068</fpage>.<pub-id pub-id-type="pmid">26896675</pub-id></mixed-citation>
</ref>
<ref id="bib117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saucedo</surname><given-names>L. J.</given-names></name><name><surname>Edgar</surname><given-names>B. A.</given-names></name></person-group>, <year>2007</year> <article-title>Filling out the Hippo pathway.</article-title>
<source/>Nat. Rev. Mol. Cell Biol.
<volume>8</volume>: <fpage>613</fpage>–<lpage>621</lpage>.<pub-id pub-id-type="pmid">17622252</pub-id></mixed-citation>
</ref>
<ref id="bib118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawyer</surname><given-names>S. L.</given-names></name><name><surname>Hartley</surname><given-names>T.</given-names></name><name><surname>Dyment</surname><given-names>D. A.</given-names></name><name><surname>Beaulieu</surname><given-names>C. L.</given-names></name><name><surname>Schwartzentruber</surname><given-names>J.</given-names></name><etal></etal></person-group>, <year>2016</year> <article-title>Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care.</article-title>
<source/>Clin. Genet.
<volume>89</volume>: <fpage>275</fpage>–<lpage>284</lpage>.<pub-id pub-id-type="pmid">26283276</pub-id></mixed-citation>
</ref>
<ref id="bib119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sayson</surname><given-names>B.</given-names></name><name><surname>Popurs</surname><given-names>M. A.</given-names></name><name><surname>Lafek</surname><given-names>M.</given-names></name><name><surname>Berkow</surname><given-names>R.</given-names></name><name><surname>Stockler-Ipsiroglu</surname><given-names>S.</given-names></name><etal></etal></person-group>, <year>2015</year> <article-title>Retrospective analysis supports algorithm as efficient diagnostic approach to treatable intellectual developmental disabilities.</article-title>
<source/>Mol. Genet. Metab.
<volume>115</volume>: <fpage>1</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">25801009</pub-id></mixed-citation>
</ref>
<ref id="bib120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaffer</surname><given-names>A. E.</given-names></name><name><surname>Eggens</surname><given-names>V. R.</given-names></name><name><surname>Caglayan</surname><given-names>A. O.</given-names></name><name><surname>Reuter</surname><given-names>M. S.</given-names></name><name><surname>Scott</surname><given-names>E.</given-names></name><etal></etal></person-group>, <year>2014</year> <article-title>CLP1 founder mutation links tRNA splicing and maturation to cerebellar development and neurodegeneration.</article-title>
<source/>Cell
<volume>157</volume>: <fpage>651</fpage>–<lpage>663</lpage>.<pub-id pub-id-type="pmid">24766810</pub-id></mixed-citation>
</ref>
<ref id="bib121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoch</surname><given-names>K.</given-names></name><name><surname>Meng</surname><given-names>L.</given-names></name><name><surname>Szelinger</surname><given-names>S.</given-names></name><name><surname>Bearden</surname><given-names>D. R.</given-names></name><name><surname>Stray-Pedersen</surname><given-names>A.</given-names></name><etal></etal></person-group>, <year>2017</year> <article-title>A recurrent de novo variant in NACC1 causes a syndrome characterized by infantile epilepsy, cataracts, and profound developmental delay.</article-title>
<source/>Am. J. Hum. Genet.
<volume>100</volume>: <fpage>343</fpage>–<lpage>351</lpage>.<pub-id pub-id-type="pmid">28132692</pub-id></mixed-citation>
</ref>
<ref id="bib122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>A. N.</given-names></name><name><surname>Davey</surname><given-names>C. F.</given-names></name><name><surname>Whitebirch</surname><given-names>A. C.</given-names></name><name><surname>Miller</surname><given-names>A. C.</given-names></name><name><surname>Moens</surname><given-names>C. B.</given-names></name></person-group>, <year>2015</year> <article-title>Rapid reverse genetic screening using CRISPR in zebrafish.</article-title>
<source/>Nat. Methods
<volume>12</volume>: <fpage>535</fpage>–<lpage>540</lpage>.<pub-id pub-id-type="pmid">25867848</pub-id></mixed-citation>
</ref>
<ref id="bib123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shashi</surname><given-names>V.</given-names></name><name><surname>Pena</surname><given-names>L. D.</given-names></name><name><surname>Kim</surname><given-names>K.</given-names></name><name><surname>Burton</surname><given-names>B.</given-names></name><name><surname>Hempel</surname><given-names>M.</given-names></name><etal></etal></person-group>, <year>2016</year> <article-title>De novo truncating variants in ASXL2 are associated with a unique and recognizable clinical phenotype.</article-title>
<source/>Am. J. Hum. Genet.
<volume>99</volume>: <fpage>991</fpage>–<lpage>999</lpage>.<pub-id pub-id-type="pmid">27693232</pub-id></mixed-citation>
</ref>
<ref id="bib124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skouloudaki</surname><given-names>K.</given-names></name><name><surname>Puetz</surname><given-names>M.</given-names></name><name><surname>Simons</surname><given-names>M.</given-names></name><name><surname>Courbard</surname><given-names>J. R.</given-names></name><name><surname>Boehlke</surname><given-names>C.</given-names></name><etal></etal></person-group>, <year>2009</year> <article-title>Scribble participates in Hippo signaling and is required for normal zebrafish pronephros development.</article-title>
<source/>Proc. Natl. Acad. Sci. USA
<volume>106</volume>: <fpage>8579</fpage>–<lpage>8584</lpage>.<pub-id pub-id-type="pmid">19439659</pub-id></mixed-citation>
</ref>
<ref id="bib125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sleven</surname><given-names>H.</given-names></name><name><surname>Welsh</surname><given-names>S. J.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name><name><surname>Churchill</surname><given-names>M. E.</given-names></name><name><surname>Wright</surname><given-names>C. F.</given-names></name><etal></etal></person-group>, <year>2017</year> <article-title>De novo mutations in EBF3 cause a neurodevelopmental syndrome.</article-title>
<source/>Am. J. Hum. Genet.
<volume>100</volume>: <fpage>138</fpage>–<lpage>150</lpage>.<pub-id pub-id-type="pmid">28017370</pub-id></mixed-citation>
</ref>
<ref id="bib126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>J. D.</given-names></name><name><surname>Hing</surname><given-names>A. V.</given-names></name><name><surname>Clarke</surname><given-names>C. M.</given-names></name><name><surname>Johnson</surname><given-names>N. M.</given-names></name><name><surname>Perez</surname><given-names>F. A.</given-names></name><etal></etal></person-group>, <year>2014</year> <article-title>Exome sequencing identifies a recurrent de novo ZSWIM6 mutation associated with acromelic frontonasal dysostosis.</article-title>
<source/>Am. J. Hum. Genet.
<volume>95</volume>: <fpage>235</fpage>–<lpage>240</lpage>.<pub-id pub-id-type="pmid">25105228</pub-id></mixed-citation>
</ref>
<ref id="bib127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sobreira</surname><given-names>N.</given-names></name><name><surname>Schiettecatte</surname><given-names>F.</given-names></name><name><surname>Boehm</surname><given-names>C.</given-names></name><name><surname>Valle</surname><given-names>D.</given-names></name><name><surname>Hamosh</surname><given-names>A.</given-names></name></person-group>, <year>2015</year><comment>a</comment> <article-title>New tools for Mendelian disease gene identification: PhenoDB variant analysis module; and GeneMatcher, a web-based tool for linking investigators with an interest in the same gene.</article-title>
<source/>Hum. Mutat.
<volume>36</volume>: <fpage>425</fpage>–<lpage>431</lpage>.<pub-id pub-id-type="pmid">25684268</pub-id></mixed-citation>
</ref>
<ref id="bib128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sobreira</surname><given-names>N.</given-names></name><name><surname>Schiettecatte</surname><given-names>F.</given-names></name><name><surname>Valle</surname><given-names>D.</given-names></name><name><surname>Hamosh</surname><given-names>A.</given-names></name></person-group>, <year>2015</year><comment>b</comment>
<article-title>GeneMatcher: a matching tool for connecting investigators with an interest in the same gene.</article-title>
<source/>Hum. Mutat.
<volume>36</volume>: <fpage>928</fpage>–<lpage>930</lpage>.<pub-id pub-id-type="pmid">26220891</pub-id></mixed-citation>
</ref>
<ref id="bib129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>St Hilaire</surname><given-names>C.</given-names></name><name><surname>Ziegler</surname><given-names>S. G.</given-names></name><name><surname>Markello</surname><given-names>T. C.</given-names></name><name><surname>Brusco</surname><given-names>A.</given-names></name><name><surname>Groden</surname><given-names>C.</given-names></name><etal></etal></person-group>, <year>2011</year> <article-title>NT5E mutations and arterial calcifications.</article-title>
<source/>N. Engl. J. Med.
<volume>364</volume>: <fpage>432</fpage>–<lpage>442</lpage>.<pub-id pub-id-type="pmid">21288095</pub-id></mixed-citation>
</ref>
<ref id="bib130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stark</surname><given-names>Z.</given-names></name><name><surname>Tan</surname><given-names>T. Y.</given-names></name><name><surname>Chong</surname><given-names>B.</given-names></name><name><surname>Brett</surname><given-names>G. R.</given-names></name><name><surname>Yap</surname><given-names>P.</given-names></name><etal></etal></person-group>, <year>2016</year> <article-title>A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders.</article-title>
<source/>Genet. Med.
<volume>18</volume>: <fpage>1090</fpage>–<lpage>1096</lpage>.<pub-id pub-id-type="pmid">26938784</pub-id></mixed-citation>
</ref>
<ref id="bib131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeshige</surname><given-names>K.</given-names></name><name><surname>Baba</surname><given-names>M.</given-names></name><name><surname>Tsuboi</surname><given-names>S.</given-names></name><name><surname>Noda</surname><given-names>T.</given-names></name><name><surname>Ohsumi</surname><given-names>Y.</given-names></name></person-group>, <year>1992</year> <article-title>Autophagy in yeast demonstrated with proteinase-deficient mutants and conditions for its induction.</article-title>
<source/>J. Cell Biol.
<volume>119</volume>: <fpage>301</fpage>–<lpage>311</lpage>.<pub-id pub-id-type="pmid">1400575</pub-id></mixed-citation>
</ref>
<ref id="bib132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarailo-Graovac</surname><given-names>M.</given-names></name><name><surname>Shyr</surname><given-names>C.</given-names></name><name><surname>Ross</surname><given-names>C. J.</given-names></name><name><surname>Horvath</surname><given-names>G. A.</given-names></name><name><surname>Salvarinova</surname><given-names>R.</given-names></name><etal></etal></person-group>, <year>2016</year> <article-title>Exome sequencing and the management of neurometabolic disorders.</article-title>
<source/>N. Engl. J. Med.
<volume>374</volume>: <fpage>2246</fpage>–<lpage>2255</lpage>.<pub-id pub-id-type="pmid">27276562</pub-id></mixed-citation>
</ref>
<ref id="bib133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Temple</surname><given-names>G.</given-names></name><name><surname>Gerhard</surname><given-names>D. S.</given-names></name><name><surname>Rasooly</surname><given-names>R.</given-names></name><name><surname>Feingold</surname><given-names>E. A.</given-names></name><name><surname>Good</surname><given-names>P. J.</given-names></name><etal></etal></person-group>, <year>2009</year> <article-title>The completion of the Mammalian Gene Collection (MGC).</article-title>
<source/>Genome Res.
<volume>19</volume>: <fpage>2324</fpage>–<lpage>2333</lpage>.<pub-id pub-id-type="pmid">19767417</pub-id></mixed-citation>
</ref>
<ref id="bib134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tifft</surname><given-names>C. J.</given-names></name><name><surname>Adams</surname><given-names>D. R.</given-names></name></person-group>, <year>2014</year> <article-title>The National Institutes of Health undiagnosed diseases program.</article-title>
<source/>Curr. Opin. Pediatr.
<volume>26</volume>: <fpage>626</fpage>–<lpage>633</lpage>.<pub-id pub-id-type="pmid">25313974</pub-id></mixed-citation>
</ref>
<ref id="bib135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toriyama</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>C.</given-names></name><name><surname>Taylor</surname><given-names>S. P.</given-names></name><name><surname>Duran</surname><given-names>I.</given-names></name><name><surname>Cohn</surname><given-names>D. H.</given-names></name><etal></etal></person-group>, <year>2016</year> <article-title>The ciliopathy-associated CPLANE proteins direct basal body recruitment of intraflagellar transport machinery.</article-title>
<source/>Nat. Genet.
<volume>48</volume>: <fpage>648</fpage>–<lpage>656</lpage>.<pub-id pub-id-type="pmid">27158779</pub-id></mixed-citation>
</ref>
<ref id="bib136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsukada</surname><given-names>M.</given-names></name><name><surname>Ohsumi</surname><given-names>Y.</given-names></name></person-group>, <year>1993</year> <article-title>Isolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae.</article-title>
<source/>FEBS Lett.
<volume>333</volume>: <fpage>169</fpage>–<lpage>174</lpage>.<pub-id pub-id-type="pmid">8224160</pub-id></mixed-citation>
</ref>
<ref id="bib137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Bokhoven</surname><given-names>H.</given-names></name><name><surname>Celli</surname><given-names>J.</given-names></name><name><surname>Kayserili</surname><given-names>H.</given-names></name><name><surname>van Beusekom</surname><given-names>E.</given-names></name><name><surname>Balci</surname><given-names>S.</given-names></name><etal></etal></person-group>, <year>2000</year> <article-title>Mutation of the gene encoding the ROR2 tyrosine kinase causes autosomal recessive Robinow syndrome.</article-title>
<source/>Nat. Genet.
<volume>25</volume>: <fpage>423</fpage>–<lpage>426</lpage>.<pub-id pub-id-type="pmid">10932187</pub-id></mixed-citation>
</ref>
<ref id="bib138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Karnebeek</surname><given-names>C. D.</given-names></name><name><surname>Bonafe</surname><given-names>L.</given-names></name><name><surname>Wen</surname><given-names>X. Y.</given-names></name><name><surname>Tarailo-Graovac</surname><given-names>M.</given-names></name><name><surname>Balzano</surname><given-names>S.</given-names></name><etal></etal></person-group>, <year>2016</year> <article-title>NANS-mediated synthesis of sialic acid is required for brain and skeletal development.</article-title>
<source/>Nat. Genet.
<volume>48</volume>: <fpage>777</fpage>–<lpage>784</lpage>.<pub-id pub-id-type="pmid">27213289</pub-id></mixed-citation>
</ref>
<ref id="bib139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venken</surname><given-names>K. J.</given-names></name><name><surname>Schulze</surname><given-names>K. L.</given-names></name><name><surname>Haelterman</surname><given-names>N. A.</given-names></name><name><surname>Pan</surname><given-names>H.</given-names></name><name><surname>He</surname><given-names>Y.</given-names></name><etal></etal></person-group>, <year>2011</year> <article-title>MiMIC: a highly versatile transposon insertion resource for engineering Drosophila melanogaster genes.</article-title>
<source/>Nat. Methods
<volume>8</volume>: <fpage>737</fpage>–<lpage>743</lpage>.<pub-id pub-id-type="pmid">21985007</pub-id></mixed-citation>
</ref>
<ref id="bib140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Al-Ouran</surname><given-names>R.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Kim</surname><given-names>S. Y.</given-names></name><name><surname>Wan</surname><given-names>Y. W.</given-names></name><etal></etal></person-group>, <year>2017</year> <article-title>MARRVEL: integration of human and model organism genetic resources to facilitate functional annotation of the human genome.</article-title>
<source/>Am. J. Hum. Genet.
<volume>100</volume>: <fpage>843</fpage>–<lpage>853</lpage>.<pub-id pub-id-type="pmid">28502612</pub-id></mixed-citation>
</ref>
<ref id="bib141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>V. Y.</given-names></name><name><surname>Hassan</surname><given-names>B. A.</given-names></name><name><surname>Bellen</surname><given-names>H. J.</given-names></name><name><surname>Zoghbi</surname><given-names>H. Y.</given-names></name></person-group>, <year>2002</year> <article-title>Drosophila atonal fully rescues the phenotype of Math1 null mice: new functions evolve in new cellular contexts.</article-title>
<source/>Curr. Biol.
<volume>12</volume>: <fpage>1611</fpage>–<lpage>1616</lpage>.<pub-id pub-id-type="pmid">12372255</pub-id></mixed-citation>
</ref>
<ref id="bib142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wangler</surname><given-names>M. F.</given-names></name><name><surname>Yamamoto</surname><given-names>S.</given-names></name><name><surname>Bellen</surname><given-names>H. J.</given-names></name></person-group>, <year>2015</year> <article-title>Fruit flies in biomedical research.</article-title>
<source/>Genetics
<volume>199</volume>: <fpage>639</fpage>–<lpage>653</lpage>.<pub-id pub-id-type="pmid">25624315</pub-id></mixed-citation>
</ref>
<ref id="bib143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wangler</surname><given-names>M. F.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Shulman</surname><given-names>J. M.</given-names></name></person-group>, <year>2017</year> <article-title>Drosophila and genome-wide association studies: a review and resource for the functional dissection of human complex traits.</article-title>
<source/>Dis. Model. Mech.
<volume>10</volume>: <fpage>77</fpage>–<lpage>88</lpage>.<pub-id pub-id-type="pmid">28151408</pub-id></mixed-citation>
</ref>
<ref id="bib144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wenger</surname><given-names>A. M.</given-names></name><name><surname>Guturu</surname><given-names>H.</given-names></name><name><surname>Bernstein</surname><given-names>J. A.</given-names></name><name><surname>Bejerano</surname><given-names>G.</given-names></name></person-group>, <year>2017</year> <article-title>Systematic reanalysis of clinical exome data yields additional diagnoses: implications for providers.</article-title>
<source/>Genet. Med.
<volume>19</volume>: <fpage>209</fpage>–<lpage>214</lpage>.<pub-id pub-id-type="pmid">27441994</pub-id></mixed-citation>
</ref>
<ref id="bib145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheeler</surname><given-names>D. A.</given-names></name><name><surname>Srinivasan</surname><given-names>M.</given-names></name><name><surname>Egholm</surname><given-names>M.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><etal></etal></person-group>, <year>2008</year> <article-title>The complete genome of an individual by massively parallel DNA sequencing.</article-title>
<source/>Nature
<volume>452</volume>: <fpage>872</fpage>–<lpage>876</lpage>.<pub-id pub-id-type="pmid">18421352</pub-id></mixed-citation>
</ref>
<ref id="bib146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>J.</given-names></name><name><surname>Mazzeu</surname><given-names>J. F.</given-names></name><name><surname>Hoischen</surname><given-names>A.</given-names></name><name><surname>Jhangiani</surname><given-names>S. N.</given-names></name><name><surname>Gambin</surname><given-names>T.</given-names></name><etal></etal></person-group>, <year>2015</year> <article-title>DVL1 frameshift mutations clustering in the penultimate exon cause autosomal-dominant Robinow syndrome.</article-title>
<source/>Am. J. Hum. Genet.
<volume>96</volume>: <fpage>612</fpage>–<lpage>622</lpage>.<pub-id pub-id-type="pmid">25817016</pub-id></mixed-citation>
</ref>
<ref id="bib147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>J. J.</given-names></name><name><surname>Mazzeu</surname><given-names>J. F.</given-names></name><name><surname>Hoischen</surname><given-names>A.</given-names></name><name><surname>Bayram</surname><given-names>Y.</given-names></name><name><surname>Withers</surname><given-names>M.</given-names></name><etal></etal></person-group>, <year>2016</year> <article-title>DVL3 alleles resulting in a -1 frameshift of the last exon mediate autosomal-dominant Robinow syndrome.</article-title>
<source/>Am. J. Hum. Genet.
<volume>98</volume>: <fpage>553</fpage>–<lpage>561</lpage>.<pub-id pub-id-type="pmid">26924530</pub-id></mixed-citation>
</ref>
<ref id="bib148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>R. M.</given-names></name><name><surname>Cech</surname><given-names>J.</given-names></name><name><surname>Ratanasirintrawoot</surname><given-names>S.</given-names></name><name><surname>Lin</surname><given-names>C. Y.</given-names></name><name><surname>Rahl</surname><given-names>P. B.</given-names></name><etal></etal></person-group>, <year>2011</year> <article-title>DHODH modulates transcriptional elongation in the neural crest and melanoma.</article-title>
<source/>Nature
<volume>471</volume>: <fpage>518</fpage>–<lpage>522</lpage>.<pub-id pub-id-type="pmid">21430780</pub-id></mixed-citation>
</ref>
<ref id="bib149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>N.</given-names></name><name><surname>Ming</surname><given-names>X.</given-names></name><name><surname>Xiao</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><etal></etal></person-group>, <year>2015</year> <article-title>TBX6 null variants and a common hypomorphic allele in congenital scoliosis.</article-title>
<source/>N. Engl. J. Med.
<volume>372</volume>: <fpage>341</fpage>–<lpage>350</lpage>.<pub-id pub-id-type="pmid">25564734</pub-id></mixed-citation>
</ref>
<ref id="bib150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>S.</given-names></name><name><surname>Jaiswal</surname><given-names>M.</given-names></name><name><surname>Charng</surname><given-names>W. L.</given-names></name><name><surname>Gambin</surname><given-names>T.</given-names></name><name><surname>Karaca</surname><given-names>E.</given-names></name><etal></etal></person-group>, <year>2014</year> <article-title>A Drosophila genetic resource of mutants to study mechanisms underlying human genetic diseases.</article-title>
<source/>Cell
<volume>159</volume>: <fpage>200</fpage>–<lpage>214</lpage>.<pub-id pub-id-type="pmid">25259927</pub-id></mixed-citation>
</ref>
<ref id="bib151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Muzny</surname><given-names>D. M.</given-names></name><name><surname>Reid</surname><given-names>J. G.</given-names></name><name><surname>Bainbridge</surname><given-names>M. N.</given-names></name><name><surname>Willis</surname><given-names>A.</given-names></name><etal></etal></person-group>, <year>2013</year> <article-title>Clinical whole-exome sequencing for the diagnosis of Mendelian disorders.</article-title>
<source/>N. Engl. J. Med.
<volume>369</volume>: <fpage>1502</fpage>–<lpage>1511</lpage>.<pub-id pub-id-type="pmid">24088041</pub-id></mixed-citation>
</ref>
<ref id="bib152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Muzny</surname><given-names>D. M.</given-names></name><name><surname>Xia</surname><given-names>F.</given-names></name><name><surname>Niu</surname><given-names>Z.</given-names></name><name><surname>Person</surname><given-names>R.</given-names></name><etal></etal></person-group>, <year>2014</year> <article-title>Molecular findings among patients referred for clinical whole-exome sequencing.</article-title>
<source/>JAMA
<volume>312</volume>: <fpage>1870</fpage>–<lpage>1879</lpage>.<pub-id pub-id-type="pmid">25326635</pub-id></mixed-citation>
</ref>
<ref id="bib153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>W. H.</given-names></name><name><surname>Sandoval</surname><given-names>H.</given-names></name><name><surname>Nagarkar-Jaiswal</surname><given-names>S.</given-names></name><name><surname>Jaiswal</surname><given-names>M.</given-names></name><name><surname>Yamamoto</surname><given-names>S.</given-names></name><etal></etal></person-group>, <year>2017</year> <article-title>Loss of Nardilysin, a mitochondrial co-chaperone for alpha-ketoglutarate dehydrogenase, promotes mTORC1 activation and neurodegeneration.</article-title>
<source/>Neuron
<volume>93</volume>: <fpage>115</fpage>–<lpage>131</lpage>.<pub-id pub-id-type="pmid">28017472</pub-id></mixed-citation>
</ref>
<ref id="bib154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Lupski</surname><given-names>J. R.</given-names></name></person-group>, <year>2015</year> <article-title>Non-coding genetic variants in human disease.</article-title>
<source/>Hum. Mol. Genet.
<volume>24</volume>: <fpage>R102</fpage>–<lpage>R110</lpage>.<pub-id pub-id-type="pmid">26152199</pub-id></mixed-citation>
</ref>
<ref id="bib155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Seeman</surname><given-names>P.</given-names></name><name><surname>Liu</surname><given-names>P.</given-names></name><name><surname>Weterman</surname><given-names>M. A.</given-names></name><name><surname>Gonzaga-Jauregui</surname><given-names>C.</given-names></name><etal></etal></person-group>, <year>2010</year> <article-title>Mechanisms for nonrecurrent genomic rearrangements associated with CMT1A or HNPP: rare CNVs as a cause for missing heritability.</article-title>
<source/>Am. J. Hum. Genet.
<volume>86</volume>: <fpage>892</fpage>–<lpage>903</lpage>.<pub-id pub-id-type="pmid">20493460</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>